Document:

Exhibit 10.1

 

Helix
TCS, Inc.

SERIES
B PREFERRED STOCK PURCHASE AGREEMENT

 

This
Series B Preferred Stock Purchase Agreement (this
“Agreement”) is made and entered into as of May 17, 2017, by and among (i) Helix
TCS, Inc., a Delaware corporation (the “Company”), (ii) Helix
Opportunities, LLC, a Delaware limited liability company (“Helix Opps”), and (iii) RSF4, LLC,
a Delaware limited liability company (the “Purchaser”).

 

Witnesseth

 

Whereas,
the Company has authorized a new series of preferred stock in its Series B Certificate of Designation (as defined below) designated
as the “Series B Preferred Stock”;

 

Whereas,
the Company has authorized the sale and issuance of the value of the Company’s Series B Preferred Stock which are to be
sold or exchanged at the First Closing and may be sold at the Subsequent Closing subject to the Maximum Amount set forth herein
(the “Series B Preferred Shares”);

 

Whereas,
the Purchaser desires to purchase the Series B Preferred Shares on the terms and conditions set forth herein; and

 

Whereas,
the Company desires to issue and sell the Series B Preferred Shares to the Purchaser on the terms and conditions set forth herein,
including, without limitation, the covenants set forth in Section 2.6.

 

Agreement

 

Now,
Therefore, in consideration of the foregoing
recitals and the mutual promises, representations, warranties, and covenants hereinafter set forth and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.          AGREEMENT
TO SELL AND PURCHASE

 

1.1        Authorization
of Series B Preferred Shares. The Company
has authorized (a) the sale and issuance to the Purchaser of the Series B Preferred Shares and (b) the issuance of such shares
of the Common Stock (as hereinafter defined) to be issued upon conversion of the Series B Preferred Shares (the “Conversion
Shares”; together with the Series B Preferred Shares, the “Shares”). The Shares have the
rights, preferences, privileges and restrictions set forth in the Charter, including that certain Certificate of Designations,
Preferences and Rights of Series B Preferred Stock in the form attached hereto as Exhibit B (the “Series
B Certificate of Designation”).

 

1.2        Sale
and Purchase. The Company hereby agrees to issue and sell to the Purchaser and, subject to and in reliance upon the
representations, warranties, covenants, terms and conditions hereof, at the Closings (as hereinafter defined), the Purchaser agrees
to purchase or otherwise acquire via exchange, as applicable, from the Company, the number of the Series B Preferred Shares set
forth opposite such Purchaser’s name on the schedule attached as Exhibit A hereto (the “Series B Schedule”)
under (i) the column heading “Series B Preferred Shares from New Money” in exchange for the payment in cash to the
Company of the New Money Commitment set forth on the Series B Schedule, and (ii) the column heading “Series B Preferred
Shares from Conversion” in exchange for the conversion value of Purchaser’s Convertible Note (as defined below), each
at a per share price equal to $0.3245385 (the “Per Share Purchase Price”).

 

     

     

    

 

2.          CLOSINGS,
DELIVERY AND PAYMENT; POST-CLOSING COVENANTS

 

2.1        Closings.

 

(a)       Multiple
Closings. The sale and purchase of the Series B Preferred Shares may occur in one or more closings (each a “Closing”
and collectively, the “Closings”). Each Closing shall be held remotely pursuant to the exchange
of electronic signature pages.

 

(b)       First
Closing. The first closing of the sale and purchase of the Series
B Preferred Shares under this Agreement (the “First Closing”) shall take place on date hereof.

 

(c)       Subsequent
Closings. At any time after the First Closing, to the extent
that (i) the Purchaser participating in the First Closing (the “Initial Purchaser”) and/or (ii) additional
purchaser(s) reasonably acceptable to the Company designated by the Initial Purchaser (each an “Additional Purchaser”),
agree by execution of a counterpart of this Agreement to purchase Series B Preferred Shares at the Per Share Purchase Price, the
Company shall, within ten (10) days thereafter, hold additional Closings with respect to the purchase of such Series B Preferred
Shares (each a “Subsequent Closing”); provided, however, that the aggregate purchase price of the Series
B Preferred Shares issued at the Subsequent Closings may not exceed $500,000 (the “Maximum Amount”),
and provided further, that all Subsequent Closings shall occur on or before December 31, 2017, and only for so long as all of
the conditions precedent to such Subsequent Closing set forth in Section 6 have been satisfied or waived. The terms of the transactions
consummated at each Subsequent Closing shall be identical to the terms consummated at the First Closing, excepting the Closing
date and the number of Series B Preferred Shares issued and sold. In connection with a Subsequent Closing, the Company shall amend
the Series B Schedule to reflect any additional purchase by the Initial Purchaser and to add any Additional Purchaser(s).

 

2.2       Use
of Proceeds. The Company shall use the proceeds
from the sale of the Series B Preferred Shares to (i) fund the acquisition described on Schedule 2.2 attached hereto and (ii)
pay in full the Bridge Notes (as defined on Schedule 2.2 attached hereto), and to the extent proceeds remain after funding the
foregoing, for working capital and general corporate purposes consistent with its business plan.

 

2.3       Payment.
The Purchaser shall pay for the Series B Preferred Shares by (a) wire transfer in accordance with instructions provided by the
Company, and/or (b) conversion of the Convertible Note as provided in Section 2.5. Purchaser shall pay an amount equal to the
Per Share Purchase Price multiplied by the number of the Series B Preferred Shares purchased.

 

    	 	2	 

     

    

 

2.4       Delivery.
At the Closings, subject to the terms and conditions
hereof and upon payment of the purchase price therefor, the Company will deliver to the Purchaser certificates, duly signed by
the President and Secretary of the Company, representing the number of the Series B Preferred Shares to be purchased at such Closing
by Purchaser (and any Additional Purchaser pursuant to any Subsequent Closing) as indicated on the Series B Schedule.

 

Convertible
Note. The parties acknowledge and agree that
immediately prior to the execution and delivery of this Agreement, the Purchaser entered into an exchange agreement pursuant to
which the Convertible Note was contributed by RSG4, LLC to Purchaser in exchange for equity interests in Purchaser. The Company
and the Purchaser acknowledge and agree that the Unsecured Convertible Promissory Note, dated September 30, 2016, in the aggregate
principal amount of $500,000 (the “Convertible Note”) issued by the Company shall convert at the First
Closing into the number of Series B Preferred Shares set forth next to Purchaser’s name under the column heading “Series
B Preferred Shares from Conversion” on the Series B Schedule. Upon such conversion, the Company will be forever released
from all of its obligations and liabilities under the Convertible Note and the Convertible Note shall be extinguished and cancelled.

 

2.6        Post-Closing
Covenants, Filings and Amendments.

 

(a)         SEC
and Delaware Secretary of State Filings.

 

(i)         Immediately
following the First Closing, the Company will cause its Board of Directors to adopt and approve by unanimous written consent,
the amended and restatement of the Original Series A Certificate of Designation, with such amendment and restatement to be effectuated
pursuant to the form attached as Exhibit G hereto (the “Amended and Restated Series A Certificate of Designation”).
The Company agrees that commencing on the date hereof and continuing until the date on which the Amended and Restated Series A
Certificate of Designation is effectively filed with the Delaware Secretary of State, the Company will not take any action to
convert or permit any holder of Series A Preferred Stock to convert into shares of Common Stock.

 

(ii)       The
Company shall prepare and file a preliminary information statement relating to the Post-Closing Consent and the Amended and Restated
Series A Certificate of Designation (together with any amendments thereof or supplements thereto, the “Information
Statement”) as soon as practicable following the date hereof (and, in any event, within five business days from
the date of this Agreement) with the Securities and Exchange Commission (the “SEC”). The Company and
Purchaser shall cooperate with each other in connection with the preparation and filing of the Information Statement. The Company
shall use its reasonable best efforts to respond (with the reasonable assistance of Purchaser) as promptly as practicable to any
comments of the SEC or its staff, and to cause the Information Statement to be delivered or otherwise made available to the Company’s
stockholders at the earliest practicable time after the resolution of all such comments in order to start the twenty day (20)
statutory notice period (with such period starting on the mailing date of the Information Statement delivery) in order to allow
the Company’s shareholders to review the Information Statement (the “Shareholder Notice Period”).
The Company shall notify Purchaser promptly of the receipt of any comments from the SEC or its staff and of any request by the
SEC or its staff for amendments or supplements to the Information Statement or for additional information and will supply Purchaser
with copies of all such correspondence.

 

    	 	3	 

     

    

 

(iii)       Within
two days business following the expiration of the Shareholder Notice Period, the Company shall cause the Amended and Restated
Series A Certificate of Designation to be filed filing (on an expedited basis) with the Delaware Secretary of State and cause
evidence of such filing and acceptance by the Delaware Secretary of State to be promptly delivered to Purchaser.

 

(b)         Purchaser
Put Right. In the event that either the Company or Helix Opps
breach any of their respective covenants set forth in this Section 2.6, upon providing two business days written notice and opportunity
to cure to the Company and Helix Opps, the Purchaser shall have the right to put to the Company all (or less than all) of its
Series B Preferred Shares at a price equal to 150% of the Per Share Purchase Price (the “Put Right Per Share Price”)
specified above, and the Company agrees to pay the Put Right Per Share Price in cash within five business days following the expiration
of the cure period described above.

 

(c)         Helix
Opps Covenants. Helix Opps agrees that commencing on the date
hereof and continuing until the date on which the Amended and Restated Series A Certificate of Designation is effectively filed
with the Delaware Secretary of State, (i) Helix Opps will not convert, nor will Helix Opps take any action to convert or permit
the Company to take any action to convert, any of the Series A Preferred Stock held by Helix into shares of Common Stock, (ii)
immediately following the First Closing, Helix will execute and deliver (and not revoke) the post-Closing consent (in its capacity
as the holder of a majority of the Common Stock and all of the Series A Preferred Stock) in the form attached as Exhibit H
hereto (the “Post-Closing Consent”), which consent approves the adoption by the Company of the Amended
and Restated Series A Certificate of Designation and the filing of such designation with the Delaware Secretary of State following
the expiration of the Shareholder Notice Period, (iii) to the extent that the Company fails to satisfy its obligations under Section
2.6(b), Helix Opps agrees to be jointly and severally for the Company’s obligations to consummate the put right transactions
described therein, and (iv) Helix Opps will use its reasonable best efforts to cause the Company to timely satisfy each of its
obligations under Section 2.6(a) and 2.6(b).

 

(d)       Purchaser
Reliance on Post-Closing Covenants. Each of the Company and
Helix Opps acknowledge and agree that the Purchaser has agreed to purchase the Series B Preferred Shares identified on the Series
B Schedule in reliance upon the covenants of the Company and Helix Opps set forth in this Section 2.6, and further acknowledge
that the Purchaser would not enter into this Agreement or any of the other transactions contemplated hereby but for the covenants
of the Company and Helix Opps set forth in this Section 2.6.

 

    	 	4	 

     

    

 

3.          REPRESENTATIONS
AND WARRANTIES OF THE COMPANY

 

Except
as set forth on a Schedule of Exceptions delivered by the Company to the Purchaser attached hereto as Exhibit F (the “Schedule
of Exceptions”), the Company, on behalf of itself and each member of the Company Group, hereby represents and warrants
to the Purchaser (and any Additional Purchaser pursuant to any Subsequent Closing) as of the date of this Agreement as set forth
below. For purposes of this Section 3, the phrase “to the Company’s knowledge” means the actual knowledge of
the executive officers of the Company.

 

3.1        Organization,
Good Standing and Qualification. The Company is a corporation duly incorporated,
validly existing and in good standing under the laws of the State of Delaware. The Company has all requisite corporate power and
authority and any government consents and approvals to (i) own and operate its properties and assets, (ii) execute and deliver
this Agreement, the Investor Rights Agreement, of even date herewith, substantially in the form attached hereto as Exhibit
C, by and among the Company and the other parties thereto (the “Investor Rights Agreement”), the
Right of First Refusal and Co-Sale Agreement, of even date herewith, substantially in the form attached hereto as Exhibit D
by and among the Company and the other parties thereto (the “Right of First Refusal and Co-Sale Agreement”),
and the Voting Agreement, of even date herewith, substantially in the form attached hereto as Exhibit E by and among the
Company and the other parties thereto (the “Voting Agreement”, together with the Investor Rights Agreement,
the Right of First Refusal and Co-Sale Agreement, the “Series B Financing Agreements”), (iii) issue
and sell the Series B Preferred Shares and the Conversion Shares, (iv) carry out the provisions of this Agreement, the Series
B Financing Agreements and the Charter and (v) carry on its business as presently conducted. The Company is duly qualified and
is authorized to do business and is in good standing as a foreign corporation in all jurisdictions in which the nature of its
activities and of its properties (both owned and leased) makes such qualification necessary, except for those jurisdictions in
which failure to do so would not have a material adverse effect on the assets, liabilities, financial condition, prospects or
operations of the Company (a “Material Adverse Effect”). For the purposes of this Agreement, the Company’s
original Certificate of Incorporation filed with the Secretary of the State of Delaware on March 13, 2014 (the “Original
Certificate”), as (i) amended on May 6, 2014 (in order to correct a misspelling), (ii) further amended on May 6,
2014, (iii) amended on October 14, 2015, (iv) amended on December 28, 2015 pursuant to an amendment which included the Certificate
of Designation of Rights and Privileges of Class A Preferred Convertible Super Majority Voting Stock (the “Original
Series A Certificate of Designation”), and (v) further amended on May 15, 2017 pursuant to an amendment which included
the Series B Certificate of Designation (the amendments described in the foregoing clauses (i)-(v), collectively, the “Charter
Amendments”, and the Original Certificate and the Amendments are together, collectively referred to herein as the
“Charter”).

 

3.2        Subsidiaries;
Strategic Partners. 

 

(a)         Schedule
3.2(a) of the Schedule of Exceptions sets forth a true and accurate list of the Company’s Subsidiaries (together with the
Company, collectively, the “Company Group”) and the equity holders of each such Subsidiary.

 

(b)         Except
as set forth on Schedule 3.2(b) of the Schedule of Exceptions, no member of the Company Group has a strategic partnership or similar
relationship with or own or have any direct or indirect interest in or control over any corporation, partnership, joint venture
or other entity of any kind.

 

(c)         The
term “Subsidiary” means any entity of which securities or other ownership interests having ordinary
voting power to elect a majority of the board of directors or other persons performing similar functions are owned directly or
indirectly by the Company.

 

    	 	5	 

     

    

 

3.3        Capitalization;
Voting Rights.

 

(a)         The
authorized capital stock of the Company, immediately prior to the First Closing consists of (i) 200,000,000 shares of common stock,
par value $0.001 per share, 28,533,411 shares of which are issued and outstanding (the “Common Stock”),
and (ii) 10,000,000 shares of Preferred Stock, par value $0.001 per share, (A) 1,000,000 of which are designated “Series A
Preferred Stock” in the Charter, as may be amended from time to time in accordance with this Agreement (the “Series
A Preferred Stock”), all of which are issued and outstanding immediately prior to the First Closing; and (B) 9,000,000
of which are designated “Series B Preferred Stock”, none of which are issued and outstanding immediately prior to
the First Closing. Section 3.3(a) of the Schedule of Exceptions sets forth the capitalization of the Company immediately prior
to the First Closing.

 

(b)         [RESERVED].

 

(c)         Other
than (i) rights to convert the Convertible Note contemplated by Section 2.5 hereof, (ii) rights to purchase additional shares
of the Common Stock vested in those persons and entities and determined as described in Section 3.3(c)(ii) of the Schedule of
Exceptions, and (iii) except as may otherwise be granted pursuant to this Agreement and the Series B Financing Agreements, there
are no outstanding options, warrants, rights (including conversion or preemptive rights and rights of first refusal), proxy or
stockholder agreements, or agreements of any kind, including agreements contingent on the occurrence of possible future events,
for the purchase or acquisition from the Company of any of its securities.

 

(d)         The
rights, preferences, privileges and restrictions applicable to the Shares are as stated in the Charter. The Conversion Shares
have been duly and validly reserved for issuance. When issued in compliance with the provisions of this Agreement and the Charter,
the Series B Preferred Shares and the Conversion Shares will be validly issued, fully paid and nonassessable, and will be free
of any liens or encumbrances other than liens and encumbrances created by Purchaser; provided, however, that the Series B Preferred
Shares and the Conversion Shares may be subject to restrictions on transfer under the Series B Financing Agreements, and state
and/or federal securities laws as set forth herein or as otherwise required by such laws at the time a transfer is proposed.

 

(e)         Except
as set forth in Section 3.3(e) of the Schedule of Exceptions, no stock plan, stock purchase, stock option or other agreement or
understanding between the Company and any holder of any equity securities or rights to purchase equity securities provides for
mandatory acceleration or other changes in the vesting provisions or other terms of such agreement or understanding as the result
of (i) termination of employment (whether actual or constructive); (ii) any merger, consolidated sale of stock or assets, change
in control or any other transaction(s) by the Company; (iii) the transactions contemplated hereby or (iv) the occurrence of any
other event or combination of events.

 

    	 	6	 

     

    

 

3.4        Authorization;
Binding Obligations.

 

(a)         All
corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization of this
Agreement and the Series B Financing Agreements, the performance of all obligations of the Company hereunder and thereunder at
the Closings, the authorization, sale, issuance and delivery of the Series B Preferred Shares pursuant hereto and the issuance
and delivery of the Conversion Shares upon conversion of the Series B Preferred Shares has been taken prior to the First Closing.

 

(b)         This
Agreement and the Series B Financing Agreements, when executed and delivered by the Company, will (assuming the due authorization,
execution and delivery hereof by the Purchaser and other parties thereto) be legal, valid and binding obligations of the Company
enforceable in accordance with their respective terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other laws of general application affecting enforcement of creditors’ rights, (b) general principles
of equity that restrict the availability of equitable remedies, and (c) to the extent that the enforceability of the indemnification
provisions in Section 2.9 of the Investor Rights Agreement may be limited by applicable laws.

 

3.5        Financial
Statements. The Company has delivered to the Purchaser its audited consolidated balance sheet as of, and statements
of income, cash flows and changes in stockholders’ equity for the period ended on December 31, 2016, and its unaudited consolidated
balance sheet as of, and statements of income, cash flows and changes in stockholders’ equity for the three-month period
ended on March 31, 2017 (such date the “Statement Date”) (all such financial statements being collectively
referred to herein as the “Financial Statements”). The Financial Statements (i) have been prepared in
accordance with generally accepted accounting principles applied on a consistent basis throughout the periods indicated, except
that the unaudited Financial Statements may not contain all footnotes required by generally accepted accounting principles, and
(ii) present fairly the financial condition of the Company Group, taken as a whole, at the date therein indicated and the results
of operations of the Company Group for the period therein specified, subject in the case of the unaudited Financial Statements
to normal year-end audit adjustments.

 

3.6        Liabilities.
Except as disclosed in Section 3.6 of the Schedule of Exceptions, no member of the Company Group has any liability (whether
known or unknown and whether absolute or contingent) having, in the aggregate, a value equal to or in excess of $10,000, except
for (a) liabilities shown in the Financial Statements, and (b) liabilities which have arisen since the Statement Date in the ordinary
course of business, and (c) performance obligations under agreements, contracts and instruments that are either disclosed in the
Schedule of Exceptions as required by this Agreement or not required to be disclosed in the Schedule of Exceptions by this Agreement
but have been entered into in the ordinary course of the business of the members of the Company Group.

 

3.7        No
Insolvency. No insolvency proceeding of any character, including, without limitation, bankruptcy, receivership, reorganization,
composition or arrangement with creditors, voluntary or involuntary, affecting the Company Group or any of its assets or properties,
is pending or, to the Company's knowledge, threatened. Neither the Company, nor any of its Subsidiaries, has taken any action
in contemplation of, or that would constitute the basis for, the institution of any such insolvency proceedings.

 

    	 	7	 

     

    

 

3.8        ERISA.
Each member of the Company Group has complied in all material respects with all applicable laws relating to wages, hours and collective
bargaining. Except as disclosed in Section 3.8 of the Schedule of Exceptions, no member of the Company Group has maintained, sponsored,
adopted, made contributions to or obligated itself to make contributions to or to pay any benefits or grant rights under or with
respect to any “Employee Pension Benefit Plan” as defined in Section 3(2) of the Employee Retirement Income Security
Act of 1974, as amended (“ERISA”), “Employee Welfare Benefit Plan” (as defined in Section 3(1)
of ERISA), “multi-employer plan” (as defined in Section 3(37) of ERISA), plan of deferred compensation, medical
plan, life insurance plan, long-term disability plan, dental plan or other plan providing for the welfare of any of the Company
Group’s or any Affiliate’s (as defined in Section 3.9 hereof) employees or former employees or beneficiaries thereof,
personnel policy, excess benefit plan, bonus or incentive plan (including but not limited to stock options, restricted stock,
stock bonus and deferred bonus plans), salary reduction agreement, change-of-control agreement, worker’s compensation law,
unemployment compensation law, social security law or any other benefit program or contract, except as required by law.

 

3.9        Agreements;
Action.

 

(a)          Except
as disclosed in Section 3.9(a) of the Schedule of Exceptions, there are no agreements, understandings or proposed transactions
between each member of the Company Group, on the one hand, and any member of the Company Group’s officers, directors, and
employees, and Affiliates or any Affiliate thereof, on the other hand. For purposes of this Agreement, an “Affiliate”
is any person who, directly or indirectly, controls, is controlled by or is under common control with any other person.

 

(b)          Except
as disclosed in Section 3.9(b) of the Schedule of Exceptions, there are no agreements, understandings, instruments, contracts,
proposed transactions, judgments, orders, writs or decrees to which any member of the Company Group is a party or by which it
is bound which may involve (i) obligations (contingent or otherwise) of, or payments to, a member of the Company Group in
excess of $25,000 (other than obligations of, or payments to, a member of the Company Group arising from purchase, sale or non-exclusive
license agreements entered into in the ordinary course of business), or (ii) the transfer or license of any patent, copyright,
trade secret or other proprietary right to or from a member of the Company Group (other than licenses arising from the purchase
of “off the shelf” or other standard products), or (iii) provisions restricting the development, manufacture
or distribution of a member of the Company Group’s products or services, or (iv) indemnification by a member of the
Company Group with respect to infringements of proprietary rights (other than indemnification obligations arising from purchase,
sale or license agreements entered into in the ordinary course of business). Section 3.9(b) of the Schedule of Exceptions sets
forth a listing of all current consultants to any member of the Company Group.

 

    	 	8	 

     

    

 

(c)          Except
as disclosed in Section 3.9(c) of the Schedule of Exceptions, no member of the Company Group has (i) declared or paid any
dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock, (ii) incurred
or guaranteed any indebtedness for money borrowed or any other liabilities (other than with respect to dividend obligations, distributions,
indebtedness and other obligations incurred in the ordinary course of business or as disclosed in the Financial Statements) individually
in excess of $25,000 or, in the case of indebtedness and/or liabilities individually less than $25,000, in excess of $50,000 in
the aggregate, (iii) made any loans or advances to any person, other than ordinary advances for travel expenses or in accordance
with the Company Group’s employee reimbursement policy, or (iv) sold, exchanged or otherwise disposed of any of its
assets or rights, other than the sale of its inventory in the ordinary course of business.

 

(d)          For
the purposes of subsections (b) and (c) above, all indebtedness, liabilities, agreements, understandings, instruments, contracts
and proposed transactions involving the same person (including persons the Company has reason to believe are affiliated therewith)
shall be aggregated for the purpose of meeting the individual minimum dollar amounts of such subsections.

 

(e)          Except
as disclosed in Section 3.9(e) of the Schedule of Exceptions, there are no agreements, understandings or proposed transactions
between each member of the Company Group, on the one hand, and Purchaser or any of its officers, directors, and employees, and
Affiliates, on the other hand.

 

3.10       Obligations
to Related Parties. Except as disclosed in Section 3.10 of the Schedule
of Exceptions, there are no obligations of any member of the Company Group to officers, directors, stockholders, or employees
of any member of the Company Group other than (a) for payment of salary for services rendered, (b) reimbursement for
reasonable expenses incurred on behalf of a member of the Company Group and (c) for other standard employee benefits made
generally available to all employees (including stock option agreements outstanding under any stock option plan approved by the
Board of Directors of the Company). None of the officers, directors or stockholders of the Company, or any members of their immediate
families, are indebted to any member of the Company Group. Except as disclosed in Section 3.10 of the Schedule of Exceptions,
none of (i) the officers or directors of the Company or any members of their immediate families, or (ii) to the Company’s
knowledge, the key employees of any member of the Company Group or any members of their immediate families, are indebted to a
member of the Company Group or have any direct or indirect ownership interest in any firm or corporation with which the Company
is affiliated or with which a member of the Company Group has a business relationship, or any firm or corporation which competes
with a member of the Company Group, other than passive investments in publicly traded companies (representing less than one percent
(1%) of such company) which may compete with a member of the Company Group. No officer, director or stockholder, or any member
of their immediate families, is, directly or indirectly, interested in any material contract with a member of the Company Group
(other than such contracts as relate to any such person’s ownership of capital stock or other securities of the Company).
Except as may be disclosed in the Financial Statements, no member of the Company Group is a guarantor or indemnitor of any indebtedness
of any other person.

 

    	 	9	 

     

    

 

3.11       Changes.
Except as set forth in Section 3.11 of the Schedule of Exceptions, since December 31, 2016, there has not been any:

 

(a)          change
in the assets, liabilities, financial condition, prospects or operations (taken as a whole) of the Company Group from that reflected
in the Financial Statements, other than changes in the ordinary course of business, none of which individually or in the aggregate
has had or is reasonably expected to have a Material Adverse Effect;

 

(b)          resignation
or termination of any officer, key employee or group of employees of any member of the Company Group; and the Company, to its
knowledge, does not know of the impending resignation or termination of employment of any such officer, key employee or group
of employees;

 

(c)          change,
except in the ordinary course of business, in the contingent obligations of the Company by way of guaranty, endorsement, indemnity,
warranty or otherwise;

 

(d)          damage,
destruction or loss, whether or not covered by insurance, except as would not have a Material Adverse Effect;

 

(e)         waiver
by a member of the Company Group of a material contractual or legal right or of a material debt owed to such member of the Company
Group;

 

(f)          change,
except in the ordinary course of business, in any compensation arrangement or agreement with any employee, officer, director or
stockholder;

 

(g)         to
the knowledge of the Company, labor organization activity related to any member of the Company Group;

 

(h)         sale,
assignment or transfer of any patents, trademarks, copyrights, trade secrets or other intangible assets, or grant of any license
with respect thereto;

 

(i)          change
in any material agreement to which a member of the Company Group is a party or by which it is bound;

 

(j)          other
event or condition of any character that, either individually or cumulatively, has had or would reasonably be expected to have
a Material Adverse Effect; or

 

(k)         arrangement
or commitment by a member of the Company Group to do any of the acts described in subsection (a) through (j) above.

 

3.12       Title
to Properties and Assets; Liens, Etc. Each member of the Company Group
has good and marketable title to its properties and assets, including the properties and assets reflected in the balance sheet
included in the Financial Statements, and good title to its leasehold estates, in each case subject to no mortgage, pledge, lien,
lease, encumbrance or charge, other than (i) those resulting from taxes which have not yet become delinquent, (ii) minor
liens and encumbrances which do not materially detract from the value of the property subject thereto or materially impair the
operations of such member of the Company Group, and (iii) those that have otherwise arisen in the ordinary course of business.
All facilities, machinery, equipment, fixtures, vehicles and other properties owned, leased or used by each member of the Company
Group are in good operating condition and repair (ordinary wear and tear excepted) and are reasonably fit and usable for the purposes
for which they are being used. Each member of the Company Group is in compliance with all material terms of each lease to which
it is a party or is otherwise bound.

 

    	 	10	 

     

    

 

3.13       Intellectual
Property.

 

(a)       Ownership.
Each member of the Company Group owns or possesses sufficient legal rights to (a) all trademarks, service marks, tradenames,
copyrights, trade secrets, licenses, information and proprietary rights and processes (the “Intellectual Property”)
and (b) to its knowledge, all patents, in each instance as used by it in connection with such member of the Company Group business,
which represent all intellectual property rights necessary to the conduct of such member of the Company Group’s business
as now conducted and as presently contemplated to be conducted, without any known conflict with, or known infringement of, the
rights of others. Section 3.13(a) of the Schedule of Exceptions contains a complete list of each member of the Company Group’s
patents, trademarks, copyrights and domain names and pending patent, trademark and copyright applications. Except for agreements
with its own employees or consultants and standard end-user license agreements and agreements identified in Section 3.13(a) of
the Schedule of Exceptions, there are no agreements relating to the Intellectual Property of any member of the Company Group,
and no member of the Company Group is bound by or a party to any agreements with respect to the Intellectual Property of any other
person. No member of the Company Group has received any written communication alleging that such member of the Company Group has
violated or, by conducting its business as currently conducted or as proposed to be conducted, would violate any of the Intellectual
Property of any other person, nor does the Company have knowledge of any reasonable basis therefor. Except as disclosed in Section
3.13(a) of the Schedule of Exceptions, (i) to the Company’s knowledge, no member of the Company Group is obligated to make
any payments by way of royalties, fees or otherwise to any owner or licensor of or claimant to any intellectual property with
respect to the use thereof in connection with the conduct of its business as presently conducted or as presently contemplated
to be conducted; (ii) there are no agreements, understandings, instruments, contracts, judgments, orders or decrees to which such
member of the Company Group is a party or by which it is bound which involve indemnification by such member of the Company Group
with respect to infringements of intellectual property; (iii) to the Company’s knowledge, no other person is infringing,
misappropriating or making unlawful use of, the Company’s Intellectual Property, and (iv) no member of the Company Group
is aware that any of its employees is obligated under any contract (including licenses, covenants or commitments of any nature)
or other agreement, or subject to any judgment, decree or order of any court or administrative agency, that would interfere with
the use of such employee’s best efforts to promote the interest of the Company Group or that would conflict with such member
of the Company Group’s business.

 

(b)       No
Breach by Employees. The Company has no knowledge that any employee of the Company Group is obligated under any contract,
or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with the use
of his or her efforts to promote the interests of the Company Group or that would conflict with the Company Group’s business
as presently conducted. Neither the execution nor delivery of this Agreement, nor the carrying on of the Company’s business
by the employees of the Company Group, nor the conduct of the Company Group’s business as presently conducted, will, to
the Company’s knowledge, conflict with or result in a breach of the terms, conditions or provisions of, or constitute a
default under, any contract, covenant or instrument under which any of such employees is now obligated.

 

    	 	11	 

     

    

 

3.14       Compliance
with Other Instruments. The Company is not in violation or default of
any term of its Charter or Bylaws or of any provision of any mortgage, indenture, contract, agreement, instrument or contract
to which it is party or by which it is bound or of any judgment, decree, order or writ. The execution, delivery, and performance
of and compliance with this Agreement and the Series B Financing Agreements, and the authorization, sale, issuance and delivery
of the Series B Preferred Shares pursuant hereto and the issuance and delivery of the Conversion Shares upon conversion of the
Series B Preferred Shares, will not, with or without the passage of time or giving of notice, result in any such violation, or
be in conflict with or constitute a default under any such term, or result in the creation of any mortgage, pledge, lien, encumbrance
or charge upon any of the properties or assets of member of the Company Group or the suspension, revocation, impairment, forfeiture
or nonrenewal of any material permit, license, authorization or approval applicable to such member of the Company Group, its business
or operations or any of its assets or properties.

 

3.15       Litigation.
There is no (a) action, suit, proceeding or investigation pending or, to the Company’s knowledge, currently threatened
against any member of the Company Group before or by any Federal, state, municipal or other governmental department, commission,
board, bureau, agency or instrumentality, domestic or foreign, (b) arbitration proceeding relating to any member of the Company
Group pending or (c) governmental inquiry pending or, to the Company’s knowledge, currently threatened against any
member of the Company Group (including without limitation any inquiry as to the qualification of the Company to hold or receive
any license or permit), nor is the Company aware that there is any basis for any of the foregoing. No member of the Company Group
is a party or subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or
instrumentality. There is no action, suit, proceeding or investigation by any member of the Company Group currently pending or
which such member of the Company Group intends to initiate.

 

3.16       Tax
Returns and Payments. Each member of the Company Group has timely filed
all tax returns and reports as required by federal, state and local law. These returns and reports are true and correct in all
material respects. Each member of the Company Group has paid all taxes and other assessments due, except those contested by it
in good faith. The provision for taxes of the Company Group as shown in the Financial Statements is adequate for taxes due or
accrued as of the date thereof. The Company has elected pursuant to the Internal Revenue Code of 1986, as amended (the “Code”),
to be treated as a corporation. During the past three (3) years, no member of the Company Group has had any tax deficiency proposed
or assessed against it and has not executed any waiver of any statute of limitations on the assessment or collection of any tax
or governmental charge. During the past three (3) years, no member of the Company Group’s federal income tax returns and
none of its state income or franchise tax or sales or use tax returns has ever been audited by governmental authorities. Each
member of the Company Group has withheld or collected from each payment made to each of its employees the amount of all taxes,
including, but not limited to, federal income taxes, Federal Insurance Contribution Act taxes and Federal Unemployment Tax Act
taxes required to be withheld or collected therefrom, and has paid the same to the proper tax receiving officers or authorized
depositaries.

 

    	 	12	 

     

    

 

3.17       Employees.
No member of the Company Group has any collective bargaining agreements with any of its employees. There is no labor union
organizing activity pending or, to the Company’s knowledge, threatened with respect to any member of the Company Group.
Except as disclosed in Section 3.17 of the Schedule of Exceptions, no member of the Company Group is a party to or bound by any
currently effective employment contract, deferred compensation arrangement, bonus plan, incentive plan, profit sharing plan, retirement
agreement or other employee compensation plan or agreement. Except as disclosed in Section 3.17 of the Schedule of Exceptions,
no officer or employee of any member of the Company Group has an employment agreement or understanding, whether oral or written,
with any member of the Company Group which is not terminable on notice by the applicable member of the Company Group without cost
or other liability to the Company Group. The Company is not aware that any officer, key employee or group of employees intends
to terminate his, her or their employment with the Company Group, nor does the Company Group have a present intention to terminate
the employment of any officer, key employee or group of employees.

 

3.18       Obligations
of Management. Each officer and key employee of the Company Group is
currently devoting substantially all of his or her business time to the conduct of the business of the Company Group. The Company
is not aware that any officer or key employee of any member of the Company Group is planning to devote less than substantially
all of his or her business time to the conduct of the Company Group in the future. No officer or key employee is currently working
or, to the Company’s knowledge, plans to work for a competitive enterprise, whether or not such officer or key employee
is or will be compensated by such enterprise.

 

3.19       Registration
and Voting Rights and Restrictions on Transfer and Issuance. Except as contemplated by the Investor Rights Agreement
and listed on Schedule 3.19, the Company is presently not under any obligation, and no person or entity has any existing rights,
to register any of the Company’s presently outstanding securities or any of its securities that may hereafter be issued.
To the Company’s knowledge, except as contemplated in the Voting Agreement, no stockholder of the Company has entered into
any currently effective agreement with respect to the voting of equity securities of the Company. Except as contemplated by the
Series B Financing Agreements, the Company is presently not under any obligation, and has not granted, any rights of first refusal,
preemptive or co-sale rights with respect to its capital stock.

 

3.20       Compliance
with Laws; Permits; Company SEC Documents.

 

(a)       Except
for violations of the Controlled Substances Act relating to cannabis’ status as a Schedule I substance, no member of the
Company Group is in violation of any applicable material statute, rule, regulation, order or restriction of any domestic or foreign
government or any instrumentality or agency thereof in respect of the conduct of its business or the ownership of its properties.
No governmental orders, permissions, consents, approvals or authorizations are required to be obtained and no registrations or
declarations are required to be filed in connection with the execution and delivery of this Agreement and the issuance of the
Series B Preferred Shares or the Conversion Shares, except such as has been duly and validly obtained or filed, or with respect
to any filings that must be made after the Closings, as will be filed in a timely manner. Each member of the Company Group has
all material franchises, permits, licenses and any similar authority necessary for the conduct of its business as now being conducted,
and believes it can obtain, without undue burden or expense, any similar authority for the conduct of its business as currently
planned to be conducted.

 

    	 	13	 

     

    

 

(b)       Except
for the Company’s failure to file its Annual Report on Form 10-K for the year ended December 31, 2016 (which Form 10-K was
filed on April 20, 2017 (the “2016 10-K”)), the Company’s forms, registration statements, reports,
schedules and statements required to be filed by it under the Exchange Act have been filed with the Commission on a timely basis.
The Company SEC Documents, at the time filed (or in the case of registration statements, solely on the dates of effectiveness),
except to the extent corrected by a subsequent Company SEC Document, (a) did not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light
of the circumstances under which they were made in the case of any such documents other than a registration statement, not misleading
and (b) complied as to form in all material respects with the applicable requirements of the Securities Exchange Act of 1934,
as amended from time to time, and the rules and regulations of the Commission promulgated thereunder (the “Exchange
Act”) and the Securities Act, as the case may be. For the purposes of this Agreement, “Company SEC Documents”
means the Company’s forms, registration statements, reports, schedules and statements filed by it under the Exchange Act
or the Securities Act, as applicable.

 

(c)       Except
as otherwise disclosed in the 2016 10-K, to the extent required by Rule 13a-15 under the Exchange Act, each member of the Company
Group has established and maintains disclosure controls and procedures (to the extent required by and as such term is defined
in Rule 13a-15(e) under the Exchange Act), (b) such disclosure controls and procedures are designed to provide reasonable assurance
that that the information required to be disclosed by the Company in the reports to be filed or submitted under the Exchange Act
is accumulated and communicated to management of the Company Group, as appropriate, to allow timely decisions regarding required
disclosure to be made and (c) to the extent required by Rule 13a-15 under the Exchange Act, such disclosure controls and procedures
are effective in all material respects to perform the functions for which they were established.

 

3.21       Environmental,
Safety and Health Laws. No member of the
Company Group is in material violation of any applicable statute, law or regulation relating to the environment or occupational
health and safety, and no material expenditures currently are, or to the Company’s knowledge will be, required in order
to comply with any such statute, law or regulation.

 

3.22       Offering
Valid. Assuming the accuracy of the representations and warranties of
Purchaser contained in Section 4.2 hereof, the offer, sale and issuance of the Series B Preferred Shares pursuant hereto
and the issuance and delivery of the Conversion Shares upon conversion of the Series B Preferred Shares will be exempt from the
registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), and will
have been registered or qualified (or are exempt from registration and qualification) under the registration, permit or qualification
requirements of all applicable state securities laws. Neither the Company nor any agent on its behalf has solicited or will solicit
any offers to sell or has offered to sell or will offer to sell all or any part of the Series B Preferred Shares to any person
or persons so as to bring the sale of such Series B Preferred Shares by the Company within the registration provisions of the
Securities Act or any state securities laws.

 

    	 	14	 

     

    

 

3.23       Necessary
Properties. The applicable member of the Company Group owns or possesses sufficient legal rights to any and all properties
reasonably necessary for the conduct of its business as now conducted.

 

3.24       Books
and Records. The books of account, ledgers, order books, records and
documents of the Company Group accurately reflect all material information relating to the businesses of the Company Group, the
location and collection of its assets, and the nature of all transactions giving rise to the obligations or accounts receivable
of the applicable member of the Company Group.

 

3.25       Insurance.
Except for the additional D&O policy coverage which will be bound prior to May 19, 2017, the Company Group maintains general
commercial, D&O, product liability, fire and casualty insurance policies with coverage customary for companies similarly situated
to the applicable member of the Company Group.

 

3.26       Disclosure.
The Company has made available to the Purchaser all the information reasonably available to the Company and its Subsidiaries
that the Purchaser have requested for deciding whether to acquire the Shares. No representation or warranty of the Company contained
in this Agreement, as qualified by the Schedule of Exceptions, and no certificate or other information furnished or to be furnished
to Purchaser at any Closing contains any untrue statement of a material fact or omits to state a material fact necessary in order
to make the statements contained herein or therein not misleading in light of the circumstances under which they were made.

 

3.27       No
Bad Actors. To its knowledge, none of the Company, any affiliated issuer, any director, executive officer, or any beneficial
owner of 20% or more of the Company's outstanding voting equity securities, calculated on the basis of voting power, nor any promoter
(as that term is defined in Rule 405 under the Securities Act) connected with the Company or any of its Subsidiaries in any capacity
(each, an “Issuer Covered Person”) is subject to any of the “Bad Actor” disqualifications
described in Securities Act Rule 506(d)(1) subsections (i) through (viii) 4 (each a “Disqualification Event”).
The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event
and each such member of the Company Group has complied, to the extent applicable, with its disclosure obligations under Rule 506(e)
promulgated under the Securities Act in respect thereto.

 

    	 	15	 

     

    

 

4.          REPRESENTATIONS
AND WARRANTIES OF THE PURCHASER.

 

Each
of Purchaser and any Additional Purchaser pursuant to any Subsequent Closing hereby represents and warrants to the Company, severally
and not jointly, as follows (such representations and warranties do not lessen or obviate the representations and warranties of
the Company set forth in this Agreement):

 

4.1        Requisite
Power and Authority. Such Purchaser has all necessary power and authority
under all applicable provisions of law to execute and deliver this Agreement and the Series B Financing Agreements and to carry
out their provisions. All action on such Purchaser’s part required for the lawful execution and delivery of this Agreement
and the Series B Financing Agreements have been or will be effectively taken prior to the applicable Closing. Upon their execution
and delivery, this Agreement and the Series B Financing Agreements will be valid and binding obligations of such Purchaser, enforceable
in accordance with their respective terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium
or other laws of general application affecting enforcement of creditors’ rights, (b) as limited by general principles
of equity that restrict the availability of equitable remedies, and (c) to the extent that the enforceability of the indemnification
provisions of Section 2.9 of the Investor Rights Agreement may be limited by applicable laws.

 

4.2        Investment
Representations. Such Purchaser understands that none of the Shares have
been registered under the Securities Act. Such Purchaser also understands that the Series B Preferred Shares and the Conversion
Shares are being offered and sold pursuant to an exemption from registration contained in the Securities Act based in part upon
such Purchaser’s representations contained in the Agreement. Such Purchaser hereby represents and warrants as follows:

 

(a)         Purchaser
Bears Economic Risk. Such Purchaser has substantial experience in evaluating and investing in private placement transactions
of securities in companies similar to the Company so that it is capable of evaluating the merits and risks of its investment in
the Company and has the capacity to protect its own interests. Such Purchaser must bear the economic risk of this investment indefinitely
unless the Shares are registered pursuant to the Securities Act, or an exemption from registration is available. Such Purchaser
understands that the Company has no present intention of registering the Shares or any shares of the Common Stock. Such Purchaser
also understands that there is no assurance that any exemption from registration under the Securities Act will be available and
that, even if available, such exemption may not allow such Purchaser to transfer all or any portion of the Shares under the circumstances,
in the amounts or at the times that such Purchaser might propose or desire.

 

(b)         Acquisition
for Own Account. Such Purchaser is acquiring the Shares for such Purchaser’s own account for investment only, and not
with a view to distribution, assignment or resale of the Shares to others or to fractionalization of the Shares in whole or in
part, in each case, in violation of the Securities Act.

 

(c)         Purchaser
Can Protect Its Interest. Such Purchaser represents that by reason of its, or of its management’s, business or financial
experience, such Purchaser has the capacity to protect its own interests in connection with the transactions contemplated in this
Agreement and the Series B Financing Agreements. Further, such Purchaser is aware of no publication of any advertisement in connection
with the transactions contemplated in the Agreement.

 

    	 	16	 

     

    

 

(d)         Accredited
Investor. Such Purchaser represents and warrants that it is an “accredited investor” within the meaning of Rule
501 of Regulation D, as promulgated under the Securities Act. Purchaser (and any Additional Purchaser pursuant to any Subsequent
Closing) that is an entity formed for the specific purpose of purchasing the Series B Preferred Shares under this Agreement represents
and warrants that, to the best of such Purchaser’s knowledge (after due inquiry), each equity owner of such Purchaser is
also an “accredited investor” within the meaning of Regulation D, as promulgated under the Securities Act.

 

(e)         Rule
144. Such Purchaser acknowledges and agrees that in addition to any requirements under state securities laws, the Series B
Preferred Shares, and, if issued, the Conversion Shares, are “restricted securities” as defined in Rule 144 promulgated
under the Securities Act as in effect from time to time (“Rule 144”) and must be held indefinitely unless
they are subsequently registered under the Securities Act or an exemption from such registration is available. Such Purchaser
has been advised or is aware of the provisions of Rule 144, which permits limited resale of shares purchased in a private placement
subject to the satisfaction of certain conditions, including, among other things, the availability of certain current public information
about the Company, the resale occurring following the required holding period under Rule 144, and the number of shares being sold
during any three-month period not exceeding specified limitations. Such Purchaser has been further advised that the Company has
no present intention of satisfying the current public information requirements of Rule 144, and as a result such Purchaser will
be able to rely on Rule 144 only under the limited circumstances described in that rule.

 

(f)         Residence.
If such Purchaser is an individual, then such Purchaser resides in the state or province identified in the address of Purchaser
set forth on the Series B Schedule; if such Purchaser is a partnership, corporation, limited liability company or other entity,
then the office or offices of such Purchaser in which its investment decision was made is located at the address or addresses
of Purchaser set forth on the Series B Schedule.

 

(g)         Foreign
Investors. If such Purchaser is not a United States person (as defined by Section 7701(a)(30) of the Code), such Purchaser
hereby represents that it has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any
invitation to subscribe for the Shares or any use of this Agreement, including (i) the legal requirements within its jurisdiction
for the purchase of the Shares, (ii) any foreign exchange restrictions applicable to such purchase, (iii) any government or other
consents that may need to be obtained, and (iv) the income tax and other tax consequences, if any, that may be relevant to the
purchase, holding, redemption, sale or transfer of the Shares. Such Purchaser’s subscription and payment for and continued
beneficial ownership of the Shares will not violate any applicable securities or other laws of such Purchaser’s jurisdiction.

 

(h)         No
General Solicitation. To the knowledge of such Purchaser, the Series B Preferred Shares have not been offered to such Purchaser
by any form of general solicitation or general advertising, including, without limitation, (A) any advertisement, article, notice
or other communication published in any newspaper, magazine or similar media, or broadcast over television or radio, or (B) any
seminar or meeting whose attendees (including the Purchaser) have been invited by any general solicitation or general advertising.

 

    	 	17	 

     

    

 

4.3       Transfer
Restrictions. Such Purchaser acknowledges and agrees that the Shares
are subject to restrictions on transfer as set forth in the Investor Rights Agreement.

 

4.4       Satisfaction
of Convertible Note. Purchaser represents that, effective as of the Closing. all indebtedness of the Company under
the Convertible Note, including any and all interest accrued thereon, shall have been paid and satisfied in full.

 

4.5       Not
a Bad Actor. No Purchaser (including any Additional Purchaser pursuant to any Subsequent Closing), and no Affiliate
(as defined below) of such Person that could stand as beneficial owner of the Securities purchased hereunder, is subject to any
of the “Bad Actor” disqualifications described in Securities Act Rule 506(d)(1) subsections (i) through (viii).

 

5.          REPRESENTATIONS
AND WARRANTIES OF HELIX OPPS.

 

Helix
Opps hereby represents and warrants to the Purchaser as follows (such representations and warranties do not lessen or obviate
the representations and warranties of the Company set forth in this Agreement):

 

5.1        Requisite
Power and Authority. Helix Opps has all necessary power and authority
under all applicable provisions of law to execute and deliver this Agreement and the Pre-Closing Consent, the Post-Closing Consent
and to carry out their provisions. All action on Helix Opps’ part required for the lawful execution and delivery of this
Agreement, the Pre-Closing Consent and the Post-Closing Consent have been or will be effectively taken. Upon their execution and
delivery, this Agreement, the Pre-Closing Consent and the Post-Closing Consent will be valid and binding obligations of Helix
Opps, enforceable in accordance with their respective terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other laws of general application affecting enforcement of creditors’ rights, (b) as limited by general
principles of equity that restrict the availability of equitable remedies.

 

6.          CONDITIONS
TO CLOSING.

 

6.1        Conditions
to Purchaser’s Obligations at Each Closing. The obligation of Purchaser
to purchase the Series B Preferred Shares to be purchased by it at each Closing is, unless waived in writing by such Purchaser,
subject to the fulfillment on or before such Closing of each of the following conditions:

 

(a)         Representations
and Warranties True. The representations and warranties made by the Company in Section 3, shall be true and correct as
of the date of the First Closing.

 

(b)         Performance
of Obligations All covenants, agreements and conditions contained in this Agreement to be performed by the Company on or prior
to such Closing shall have been performed or complied with in all material respects.

 

    	 	18	 

     

    

 

(c)         Qualifications.
All authorizations, approvals or permits, if any, of any governmental authority or regulatory body of the United States or
of any state that are required in connection with the lawful issuance and sale of the Series B Preferred Shares and the Conversion
Shares pursuant to this Agreement shall be obtained and effective as of such Closing.

 

(d)         Filing
of Series B Certificate of Designation. The Series B Certificate of Designation shall have been filed with the Secretary of
State of the State of Delaware and shall be in full force and effect as of the First Closing.

 

(e)         Reservation
of Conversion Shares. The Conversion Shares shall have been duly authorized and reserved for issuance.

 

(f)          Certificates.
The Company shall have delivered to counsel to the Purchaser the following:

 

(i)          a
certificate executed by the Chief Executive Officer, President or Chief Financial Officer of the Company on behalf of the Company,
certifying the satisfaction of the conditions to closing listed in Sections 5.1(a) and (b) as of the date of such Closing;

 

(ii)         a
certificate of the Secretary of State of the State of Delaware, dated as of a date within five (5) days of the date of the applicable
Closing, with respect to the good standing of the Company; and

 

(iii)        a
certificate of the Company executed by the Company’s Secretary, attaching and certifying to the truth and correctness of
(1) the Charter, (2) the Bylaws (3) the board and stockholder resolutions adopted in connection with the transactions
contemplated by this Agreement, dated as of or prior to such Closing, and (4) the stockholder written consent of Helix Opps adopted
in its capacity as the holder of all of the Series A Preferred Stock in connection with the transactions contemplated by this
Agreement, dated as or prior to such Closing (the “Pre-Closing Consent”).

 

(g)         Board
of Directors. Upon the date of the First Closing, the members of the Board of Directors of the Company shall consist of the
persons named in the Voting Agreement.

 

(h)         Execution
of Counterpart. The Company shall have delivered to the Purchaser an executed counterpart of this Agreement and each of the
Series B Financing Agreements.

 

6.2        Conditions
to Obligations of the Company to Close. The Company’s obligation
to issue and sell the Series B Preferred Shares at each Closing is subject to the satisfaction of the following conditions:

 

(a)         Representations
and Warranties True. The representations and warranties in Section 4 made by such Purchaser shall be true and correct
as of such Closing, with the same force and effect as if they had been made on and as of the date of such Closing.

 

    	 	19	 

     

    

 

(b)         Performance
of Obligations. Purchaser shall have performed and complied with all agreements and conditions herein required to be performed
or complied with by such Purchaser on or before such Closing.

 

(c)         Execution
of Counterpart. The Company shall have received from the Purchaser an executed counterpart of this Agreement and each of the
Series B Financing Agreements.

 

(d)         Consents,
Permits, and Waivers. The Company shall have obtained any and all consents, permits and waivers necessary or appropriate for
consummation of the transactions contemplated by the Agreement and the Series B Financing Agreements.

 

7.          MISCELLANEOUS.

 

7.1        Governing
Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by and construed in accordance
with the General Corporation Law of the State of Delaware, without regard to its principles of conflicts of laws. Each of the
parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of Delaware located in Wilmington,
Delaware and the United States District Court for the District of Delaware for the purpose of any suit, action, proceeding or
judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection
with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified
for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such
court in any such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any
objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim
that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES
HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL
HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

 

7.2        Successors
and Assigns. Except as otherwise expressly provided herein, the provisions
hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the
parties hereto and shall inure to the benefit of and be enforceable by each person who shall be a holder of the Series B Preferred
Shares from time to time.

 

7.3        Entire
Agreement. This Agreement, the exhibits and schedules hereto, the Series
B Financing Agreements and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement
between the parties with regard to the subjects hereof and no party shall be liable or bound to any other in any manner by any
representations, warranties, covenants and agreements except as specifically set forth herein and therein.

 

7.4        Severability.
In case any provision of the Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

 

    	 	20	 

     

    

 

7.5        Amendment
and Waiver.

 

(a)         This
Agreement may be amended or modified only upon the written consent of the Company and holders of at least a majority of the Series
B Preferred Shares then outstanding (treated as if converted and including any Conversion Shares into which the Series B Preferred
Shares have been converted that have not been sold to the public). Any such amendment or modification effected in accordance with
this Section 7.5(a) shall be binding on all parties hereto, even if they do not execute such consent.

 

(b)         Subject
to Section 7.5(c) below, any party hereto may waive compliance with any agreements, covenants or conditions for the benefit of
such party contained herein. Any agreement on the part of a party hereto to any such waiver shall be valid only if set forth in
an instrument in writing signed on behalf of such party.

 

(c)         The
obligations of the Company and the rights of the holders of the Series B Preferred Shares and the Conversion Shares under the
Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the
written consent of the holders of at least a majority of the Series B Preferred Shares then outstanding (treated as if converted
and including any Conversion Shares into which the Series B Preferred Shares have been converted that have not been sold to the
public). Any such waiver effected in accordance with this Section 7.5(c) shall be binding on all parties hereto, even if they
do not execute such consent.

 

7.6        Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party, upon any breach, default
or noncompliance by another party under this Agreement, the Series B Financing Agreements or the Charter, shall impair any such
right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence
therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver,
permit, consent or approval of any kind or character on Purchaser’s part of any breach, default or noncompliance under this
Agreement, the Series B Financing Agreements or under the Charter or any waiver on such party’s part of any provisions or
conditions of the Agreement, the Series B Financing Agreements or the Charter must be in writing and shall be effective only to
the extent specifically set forth in such writing. All remedies, either under this Agreement, the Series B Financing Agreements,
the Charter, by law, or otherwise afforded to any party, shall be cumulative and not alternative.

 

7.7        Notices.
All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal
delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours
of the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt.

 

7.8        Expenses.
The Company and the Purchaser shall each pay their own expenses in connection with the transactions contemplated by this
Agreement; provided, however that if the First Closing is effected, the Company shall pay the reasonably documented fees and expenses
of corporate counsel for the Purchaser and their investors, in an amount not to exceed $60,000.

 

    	 	21	 

     

    

 

7.9        Attorneys’
Fees. In the event that any suit or action is instituted to enforce any
provision in this Agreement, the prevailing party in such dispute shall be entitled to recover from the losing party all fees,
costs and expenses of enforcing any right of such prevailing party under or with respect to this Agreement, including without
limitation, such reasonable fees and expenses of attorneys and accountants, which shall include, without limitation, all fees,
costs and expenses of appeals.

 

7.10       Titles
and Subtitles. The titles of the sections and subsections of the Agreement
are for convenience of reference only and are not to be considered in construing this Agreement.

 

7.11       Pronouns.
All pronouns contained herein, and any variations thereof, shall be deemed to refer to the masculine, feminine or neutral,
singular or plural, as to the identity of the parties hereto may require.

 

7.12       Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall
constitute one instrument. This Agreement may be executed by facsimile signatures or via .pdf signature.

 

Signatures
on the Following Page

 

    	 	22	 

     

    

 

This
Series B Preferred Stock Purchase Agreement is hereby executed as of the
date first above written.

 

The
Company:

 

Helix
TCS, Inc.

 

	By:	 	 
	Name:	Zachary
    L. Venegas	 
	Title:	Chief
    Executive Officer	 

 

HELIX
OPPS:

 

Helix
Opportunities, LLC

 

	By:	 	 
	Name:	Zachary
    L. Venegas	 
	Title:	Manager	 

 

The
Purchaser: 

 

RSF4,
LLC

 

	By:	 	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 

 

HELIX
TCS, INC. SERIES B PREFERRED STOCK PURCHASE AGREEMENT

SIGNATURE
PAGEExhibit
10.2

 

HELIX
TCS, INC.

INVESTOR
RIGHTS AGREEMENT

 

This
Investor Rights Agreement (this “Agreement”)
is entered into as of May 17, 2017 by and among Helix TCS, Inc., a
Delaware corporation (the “Company”), and the Investors listed on Exhibit
A attached to this Agreement, including Rose Capital (collectively, the “Investors” and each,
without distinction among them, an “Investor”).

 

Recitals

 

Whereas,
certain of the Investors are holders of the Company’s
Series A Preferred Stock (the “Series A Preferred”); and

 

Whereas,
RSF4, LLC, a Delaware limited liability company
(“Rose Capital”), concurrent with the execution of this Agreement, is purchasing shares of the Company’s
Series B Preferred Stock (the “Series B Preferred”, together with the Series A Preferred, the “Preferred”)
pursuant to that certain Series B Preferred Stock Purchase Agreement of even date herewith (the “Purchase Agreement”),
by and between the Company and Rose Capital; and

 

WHEREAS,
the Company and the Prior Investors desire to enter into this Agreement to provide Rose Capital with the rights and privileges
set forth herein.

 

Agreement

 

Now,
Therefore, in
consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto agree as follows:

 

SECTION
1. GENERAL.

 

1.1       Definitions.
As used in this Agreement the following terms shall have the following respective meanings:

 

(a)       “Change
in Control” means (i) the sale of substantially all of the assets of the Company, (ii) the consolidation or merger
of the Company with or into any other corporation or other entity or person or any other corporate reorganization, in which the
capital stock of the Company prior to such consolidation, merger or reorganization, represents less than fifty percent (50%) of
the voting power of the surviving entity immediately after such consolidation, merger or reorganization; or (iii) any “person”
or “group” (as such terms are used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act or any successor provisions
to either of the foregoing), including any group acting for the purpose of acquiring, holding, voting or disposing of securities
within the meaning of Rule 13d-5(b)(1) of the Exchange Act (other than Helix Opportunities LLC or any of its Affiliates),
becomes after the date of this Agreement the “beneficial owner” (as such term is defined in Rule 13d-3 of the
Exchange Act (provided that a Person will be deemed to have “beneficial ownership” of all shares that any such
Person has the right to acquire, whether such right is exercisable immediately or only after the passage of time)), directly or
indirectly, 50% or more of voting stock of the Company, provided, however, that (A) any consolidation or merger effected
exclusively to change the domicile of the Company, or (B) any transaction or series of transactions principally for bona fide
equity financing purposes in which cash is received by the Company or indebtedness of the Company is cancelled or converted
or a combination thereof, shall not constitute a Change in Control.

 

     

     

    

 

(b)       “Charter”
has the meaning ascribed to such term in the Purchase Agreement.

 

(c)       “Common
Stock” means shares of the Company’s common stock, par value $0.001 per share, as so designated in the Restated
Certificate.

 

(d)       “Equity
Securities” means (i) any Common Stock, the Preferred or other security of the Company, (ii) any security
convertible, with or without consideration, into any Common Stock, the Preferred or other security (including any option to purchase
such a convertible security), (iii) any security carrying any warrant or right to subscribe to or purchase any Common Stock,
the Preferred or other security, or (iv) any such warrant or right.

 

(e)       “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(f)       “Form
S-3” means such form under the Securities Act as in effect on the date hereof or any successor or similar registration
form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information
by reference to other documents filed by the Company with the SEC.

 

(g)       “Holder”
means any Investor owning of record Registrable Securities that have not been sold to the public or any assignee of record
of such Registrable Securities in accordance with Section 2.10 hereof.

 

(h)       “Initial
Offering” means the Company’s first firm commitment underwritten public offering of its Common Stock registered
under the Securities Act.

 

(i)         “Management
Services” means management, consulting and advisory services provided by Rose Management to the Company as requested
from time to time by the Company, including (i) advice in connection with the structuring, negotiation and consummation of strategic
transactions, including raising new equity capital, and commercial agreements; (ii) financial, business, managerial and strategic
advice in connection with the business of the Company and its subsidiaries, including, without limitation, advice with respect
to the development and implementation of strategies for improving the operating, marketing and financial performance of the Company
and its subsidiaries; (iii) advice in connection with potential joint ventures and other strategic initiatives; and (iv) financial
and strategic planning and analysis, consulting services, and executive recruitment services and other services.

 

(j)        “Proprietary
Rights” means patents, trademarks, trade names, know-how, rights in trade dress and packaging, and shop rights,
copyrights, inventions, trade secrets, service marks and all other intellectual property rights, in each case whether registered
or not and in each case wherever such rights exist throughout the world, and including the right to recover for any past infringement.

 

    	 	2	 

     

    

 

(k)       “Register,”
“registered,” and “registration” refer to a registration effected by preparing and
filing a registration statement in compliance with the Securities Act, and the declaration or ordering of effectiveness of such
registration statement or document.

 

(l)        “Registrable
Securities” means (i) Common Stock issued or issuable upon conversion of the Preferred and (ii) any other
shares of Common Stock held beneficially or of record (or issuable upon the conversion or exercise of any warrant, right or other
security which is held beneficially or of record) by a holder of the securities described in the foregoing clause (i). Notwithstanding
the foregoing, Registrable Securities shall not include any securities sold by a person to the public either pursuant to a registration
statement or Rule 144 or sold in a private transaction in which the transferor’s rights under Section 2 of this
Agreement are not assigned.

 

(m)       “Registrable
Securities Deemed Outstanding” means the shares of the Company’s Common Stock that are Registrable Securities
that are either: (i) then issued and outstanding, or (ii) issuable upon the exercise or conversion of vested rights under exercisable
or convertible securities.

 

(n)       “Registration
Expenses” means all expenses incurred by the Company in complying with Sections 2.2, 2.3 and 2.4 hereof, including,
without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, reasonable
fees and disbursements not to exceed $32,500 for a single special counsel for the Holders, blue sky fees and expenses and the
expense of any special audits incident to or required by any such registration (but excluding the compensation of regular employees
of the Company which shall be paid in any event by the Company).

 

(o)       “Rule 144” means Rule 144, as promulgated under the Securities Act, or any similar or analogous rule promulgated
under the Securities Act.

 

(p)       “SEC”
or “Commission” means the Securities and Exchange Commission.

 

(q)       “Securities
Act” means the Securities Act of 1933, as amended.

 

(r)       “Selling
Expenses” means all underwriting discounts and selling commissions applicable to the sale.

 

(s)       “Special
Registration Statement” means (i) a registration statement relating to any employee benefit plan, (ii) with respect
to any corporate reorganization or transaction under Rule 145 of the Securities Act, any registration statements related
to the resale of securities issued in such a transaction, or (iii) a registration related to stock issued upon conversion of debt
securities.

 

(t)        “State
Securities Laws” means all applicable state securities laws and regulations, including, without limitation, the
registration, permit or qualification requirements thereunder.

 

    	 	3	 

     

    

 

SECTION
2.RESTRICTIONS
ON TRANSFER; REGISTRATION.

 

2.1       Restrictions
on Transfer.

 

(a)       Each
Holder agrees not to make any disposition of all or any portion of Registrable Securities unless and until:

 

(i)          There
is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is
made in accordance with such registration statement; or

 

(ii)        (A) The
transferee has agreed in writing to be bound by the terms of this Agreement, (B) such Holder shall have notified the Company
of the proposed disposition and shall have furnished the Company with a detailed statement of the circumstances surrounding the
proposed disposition, and (C) if reasonably requested by the Company, such Holder shall have furnished the Company with an
opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares
under the Securities Act and applicable state and foreign securities law. Notwithstanding the foregoing, no such opinion of counsel
shall be required in connection with any transfer of shares of Registrable Securities made in compliance with Rule 144.

 

(iii)       Notwithstanding
the provisions of paragraphs (i) and (ii) above, no such registration statement or opinion of counsel shall be necessary
for a transfer by a Holder that is (A) a partnership transferring to its partners or former partners in accordance with partnership
interests, (B) a corporation transferring to a wholly-owned subsidiary or a parent corporation that owns all of the capital
stock of the Holder, (C) a limited liability company transferring to its members or former members in accordance with their
interest in the limited liability company, or (D) a natural person and the transfer is to any family member or to a trust
established for the benefit of such natural person and/or any member of such person’s family, (E) a trust and the transfer
is to any other trust or to any person that is a beneficiary of the transferring trust or (F) is a natural person and such transfer
occurs as a matter of law upon the death or declaration of incompetence of such Holder; provided, however, that in each
case the transferee will be subject to the terms of this Agreement to the same extent as if the transferee were an original Holder
hereunder.

 

(b)       Each
certificate representing Registrable Securities shall (unless otherwise permitted by the provisions of the Agreement) be stamped
or otherwise imprinted with a legend substantially similar to the following (in addition to any legend required under State Securities
Laws):

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY
STATE SECURITIES LAW. NEITHER THIS SECURITY NOR ANY PORTION HEREOF OR INTEREST HEREIN MAY BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED
OR OTHERWISE DISPOSED OF UNLESS THE SAME IS REGISTERED UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAW, OR UNLESS AN EXEMPTION
FROM SUCH REGISTRATION IS AVAILABLE AND THE COMPANY SHALL HAVE RECEIVED, AT THE EXPENSE OF THE HOLDER HEREOF, EVIDENCE OF SUCH
EXEMPTION REASONABLY SATISFACTORY TO THE COMPANY (WHICH MAY INCLUDE, AMONG OTHER THINGS, AN OPINION OF COUNSEL SATISFACTORY TO
THE COMPANY).

 

    	 	4	 

     

    

 

THE
SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS
OF A CERTAIN INVESTOR RIGHTS AGREEMENT BY AND BETWEEN THE STOCKHOLDER AND THE COMPANY. COPIES OF SUCH AGREEMENT MAY BE OBTAINED
UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.

 

(c)       The
Company shall be obligated to reissue promptly unlegended certificates at the request of any Holder thereof if the Holder shall
have obtained an opinion of counsel (which counsel may be counsel to the Company) reasonably acceptable to the Company to the
effect that the securities proposed to be disposed of may lawfully be so disposed of without registration, qualification or legend.

 

(d)       Any
legend endorsed on an instrument pursuant to State Securities Laws and the stop-transfer instructions with respect to such securities
shall be removed upon receipt by the Company of an order of the appropriate blue sky authority authorizing such removal.

 

(e)       The
restrictions set forth in this Section 2.1 shall terminate upon completion of the Company’s Initial Offering.

 

2.2       Demand
Registration.

 

(a)       Subject
to the conditions of this Section 2.2, if the Company shall receive a written request from the Holders of not less than twenty-five
percent (25%) of the outstanding shares of the Registrable Securities (the “Initiating Holders”) that
the Company file a registration statement under the Securities Act having an aggregate offering price to the public of not less
than $20,000,000 (a “Qualified Public Offering”), then the Company shall, within thirty (30) days of
the receipt thereof, give written notice of such request to all Holders, and subject to the limitations of this Section 2.2, the
Company shall use its commercially reasonable efforts to effect the registration under the Securities Act of all Registrable Securities
that the Holders request to be registered.

 

(b)       If
the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they
shall so advise the Company as a part of their request made pursuant to this Section 2.2 or any request pursuant to Section 2.4
and the Company shall include such information in the written notice referred to in Section 2.2(a) or Section 2.4(a),
as applicable. In such event, the right of any Holder to include its Registrable Securities in such registration shall be conditioned
upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in
the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting
shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting
by a majority in interest of the Initiating Holders (which underwriter or underwriters shall be reasonably acceptable to the Company).
Notwithstanding any other provision of this Section 2.2 or Section 2.4, if the underwriter advises the Company that
marketing factors require a limitation of the number of securities to be underwritten (including Registrable Securities) then
the Company shall so advise all Holders of Registrable Securities which would otherwise be underwritten pursuant hereto, and the
number of shares that may be included in the underwriting shall be allocated to the Holders of such Registrable Securities on
a pro rata basis based on the number of Registrable Securities held by all such Holders (including the Initiating Holders);
provided, however, that the number of shares of Registrable Securities to be included in such underwriting and registration
shall not be reduced unless all other outstanding securities of the Company are first entirely excluded from the underwriting
and registration. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration.
A registration statement shall not be counted if, as a result of an exercise of the underwriter's cut-back provisions, fewer than
25% of the total number of Registrable Securities that Holders have requested to be included in such registration statement are
actually included.

 

    	 	5	 

     

    

 

(c)       The
Company shall not be required to effect a registration pursuant to this Section 2.2:

 

(i)          prior
to the earlier of (A) the third anniversary of the date of this Agreement, or (B) one hundred eighty (180) days following the
effective date of the registration statement pertaining to the Initial Offering;

 

(ii)        after
the Company has effected two (2) registrations pursuant to this Section 2.2, and such registrations have been declared or
ordered effective;

 

(iii)       during
the period starting with the date of filing of, and ending on the date one hundred eighty (180) days following the effective date
of, the registration statement on Form S- or any similar or successor form pertaining to the Initial Offering; provided, however,
that the Company makes a reasonable good faith effort to effect such registration as soon thereafter as practicable;

 

(iv)        prior
to ninety (90) days after the first follow-on offering of the Company’s Common Stock to the public that is registered under
the Securities Act and follows the Initial Offering;

 

(v)         if
within thirty (30) days of receipt of a written request from Initiating Holders pursuant to Section 2.2(a), the Company gives
notice to the Holders of the Company’s intention to file a registration statement with respect to the Initial Offering within
ninety (90) days;

 

(vi)        if
the Registrable Securities to be included in the registration statement could be sold without restriction under SEC Rule 144 within
a ninety (90) day period and the Company is currently subject to the periodic reporting requirements of Section 12(g) or 15(d)
of the Exchange Act;

 

(vii)       if
the Company shall furnish to Holders requesting a registration pursuant to this Section 2.2, a certificate signed by (A)
the Chairman of the Board of Directors of the Company (the “Board”) or (B) a majority of the then-serving
members of the Board stating that in their good faith judgment, it would directly, materially and adversely affect the Company
and its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right
to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided,
however, that such right to delay a request together with the similar right pursuant to Section 2.4(b)(v) shall be exercised
by the Company not more than once in any twelve (12) month period;

 

    	 	6	 

     

    

 

(viii)       if
the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3
pursuant to a request made pursuant to Section 2.4 below; or

 

(ix)       in
any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance.

 

2.3       Piggyback
Registrations.

 

(a)       The
Company shall notify all Holders of Registrable Securities in writing at least fifteen (15) days prior to the filing of any registration
statement under the Securities Act for purposes of a public offering of securities of the Company solely for cash (including,
but not limited to, registration statements relating to secondary offerings of securities of the Company, but excluding Special
Registration Statements) and will afford each such Holder an opportunity to include in such registration statement all or part
of such Registrable Securities held by such Holder. Each Holder desiring to include in any such registration statement all or
any part of the Registrable Securities held by it shall, within ten (10) business days after the above-described notice from the
Company, so notify the Company in writing and the Company will use its commercially reasonable efforts to cause the Registrable
Securities so requested by such Holder to be included in such registration statement. Such notice shall state the intended method
of disposition of the Registrable Securities by such Holder. If a Holder decides not to include all of such Holder’s Registrable
Securities in any registration statement thereafter filed by the Company, such Holder shall nevertheless continue to have the
right to include any Registrable Securities in any subsequent registration statement or registration statements as may be filed
by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein.

 

(b)       If
the registration statement under which the Company gives notice under this Section 2.3 is for an underwritten offering, the
Company shall so advise the Holders of Registrable Securities. In such event, the right of any such Holder to be included in a
registration pursuant to this Section 2.3 shall be conditioned upon such Holder’s participation in such underwriting
and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders
proposing to distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary
form with the underwriter or underwriters selected for such underwriting by the Company. Notwithstanding any other provision of
this Agreement, if the underwriter determines in good faith that marketing factors require a limitation of the number of shares
to be underwritten, the number of shares that may be included in the underwriting shall be allocated, first, to the Company; second,
to the Holders on a pro rata basis based on the total number of Registrable Securities offered for sale by the Holders;
and third, to any stockholder of the Company (other than a Holder) on a pro rata basis, provided, however, that
no such reduction shall reduce the amount of securities of the selling Holders included in the registration below thirty percent
(30%) of the total amount of securities included in such registration unless such offering is the Initial Offering, in which case,
the selling Holders may be excluded. In no event will shares of any other selling stockholder be included in such registration
that would reduce the number of shares that may be included by Holders without the written consent of Holders of not less than
sixty-six and two-thirds percent (66 2/3%) of the Registrable Securities proposed to be sold in the offering. If any Holder disapproves
of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter,
delivered at least ten (10) business days prior to the effective date of the registration statement. Any Registrable Securities
excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration. For any Holder which is a
partnership or corporation, the partners, retired partners and stockholders of such Holder, or the estates and family members
of any such partners and retired partners and any trusts for the benefit of any of the foregoing persons shall be deemed to be
a single “Holder,” and any pro rata reduction with respect to such “Holder” shall be based upon
the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such “Holder,”
as defined in this sentence.

 

    	 	7	 

     

    

 

(c)       The
Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.3 prior to the
effectiveness of such registration whether or not any Holder has elected to include securities in such registration. The Registration
Expenses of such withdrawn registration shall be borne by the Company in accordance with Section 2.5 hereof.

 

2.4       Short
Form Registration. In the event the Company
shall receive from any Holder or Holders of not less than twenty percent (20%) of the Registrable Securities a written request
or requests that the Company effect a registration on Form S-3, or any successor or any similar short-form registration statement
(a “Short Form Registration Statement”) and any related qualification or compliance with respect to
all or a part of the Registrable Securities owned by such Holder or Holders, the Company will use its commercially reasonable
efforts to:

 

(a)       promptly
give written notice of the proposed registration, and any related qualification or compliance, to all other Holders of Registrable
Securities;

 

(b)       subject
to any comments from the Securities and Exchange Commission, include as part of such Short Form Registration Statement a plan
of distribution in form and substance satisfactory to Rose Capital; provided, however, that no Holder shall be named as an “underwriter”
in such Short Form Registration Statement without the Holder’s prior written consent; and

 

(c)       as
soon as practicable, effect such registration and all such qualifications and compliances as may be so requested and as would
permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities
as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder or Holders
joining in such request as are specified in a written request given within fifteen (15) business days after receipt of such written
notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration, qualification
or compliance pursuant to this Section 2.4:

 

(i)          if
the Company has, within the twelve (12) month period preceding the date of such request, already effected two (2) registrations
on Form S-3, Form S-2 or any similar short form registration statement for the Holders pursuant to this Section 2.4;

 

    	 	8	 

     

    

 

(ii)       if
Form S-3 is not available to the Company for such offering by the Holders;

 

(iii)      if
the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose
to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of less than $5,000,000;

 

(iv)       if
within thirty (30) days of receipt of a written request from Initiating Holders pursuant to Section 2.4, the Company gives
notice to the Holders of the Company’s intention to file a registration statement for a public offering, other than pursuant
to a Special Registration Statement within ninety (90) days;

 

(v)        if
the Company shall furnish to the Holders a certificate signed by (A) the Chairman of the Board or (B) a majority of the then-serving
members of the Board, stating that in the good faith judgment of the Board, it would directly, materially and adversely effect
the Company and its stockholders for such Form S-3 registration to be effected at such time, in which event the Company shall
have the right to defer the filing of the Form S-3 registration statement for a period of not more than ninety (90) days
after receipt of the request of the Holder or Holders under this Section 2.4; provided, however, that such right to
delay a request together with the similar right pursuant to Section 2.2(c)(vii) shall be exercised by the Company not more than
once in any twelve (12) month period; or

 

(vi)       in
any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance.

 

(d)       Subject
to the foregoing, the Company shall file a Form S-3 or Form S-2, as applicable, registration statement covering the Registrable
Securities and other securities so requested
to be registered as soon as practicable after receipt of the requests of the Holders.

 

2.5       Expenses
of Registration. Except as specifically provided
herein, all Registration Expenses incurred in connection with any registration, qualification or compliance pursuant to Sections 2.2,
2.3 or 2.4 hereof shall be borne by the Company. All Selling Expenses incurred in connection with any registrations hereunder
shall be borne by the holders of the securities so registered, pro rata on the basis of the number of shares so registered.
The Company shall not, however, be required to pay for expenses of any registration proceeding begun pursuant to Section 2.2
or 2.4, the request of which has been subsequently withdrawn by the Initiating Holders unless (a) the withdrawal is based
upon material adverse information concerning the Company of which the Initiating Holders were not notified in writing by the Company
prior to the time of such request, or (b) the Holders of a majority of Registrable Securities agree to forfeit their right
to one requested registration pursuant to Section 2.2, in which event such right shall be forfeited by all Holders. If the
Holders are required to pay the Registration Expenses, such expenses shall be borne by the holders of securities (including Registrable
Securities) requesting such registration in proportion to the number of shares for which registration was requested. If the Company
is required to pay the Registration Expenses of a withdrawn offering pursuant to clause (a) above, then the Holders shall
not forfeit their rights pursuant to Section 2.2 or to a demand registration.

 

    	 	9	 

     

    

 

2.6       Obligations
of the Company. Whenever required to effect
the registration of any Registrable Securities, the Company shall, use its commercially reasonable efforts to:

 

(a)       Prepare
and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable
efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable
Securities registered thereunder, keep such registration statement effective for up to ninety (90) days or, if earlier, until
the Holder or Holders have completed the distribution related thereto; provided, however, that at any time, upon written
notice to the participating Holders and for a period not to exceed sixty (60) days thereafter (the “Suspension Period”),
the Company may delay the filing or effectiveness of any registration statement or suspend the use or effectiveness of any registration
statement (and the Initiating Holders hereby agree not to offer or sell any Registrable Securities pursuant to such registration
statement during the Suspension Period) if the Company reasonably believes that the Company may, in the absence of such delay
or suspension hereunder, be required under state or federal securities laws to disclose (i) any corporate development the disclosure
of which could reasonably be expected to have a material adverse effect upon the Company or its stockholders, (ii) a potentially
significant transaction or event involving the Company, or (iii) any negotiations, discussions, or proposals directly relating
thereto. No more than two (2) such Suspension Periods shall occur in any twelve (12) month period. In the event that the Company
shall exercise its rights hereunder, the applicable time period during which the registration statement is to remain effective
shall be extended by a period of time equal to the duration of the Suspension Period. The Company may extend the Suspension Period
for an additional consecutive sixty (60) days with the consent of the sixty-six and two-thirds percent (66 2/3%) of the Registrable
Securities proposed to be sold by the Initiating Holders, which consent shall not be unreasonably withheld. If so directed by
the Company, the Initiating Holders shall use their reasonable efforts to deliver to the Company (at the Company’s expense)
or destroy all copies, other than permanent file copies then in such Initiating Holders’ possession, of the prospectus relating
to such Registrable Securities current at the time of receipt of such notice. The Company shall not be required to file, cause
to become effective or maintain the effectiveness of any registration statement that contemplates a distribution of securities
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act.

 

(b)       Prepare
and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with
such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement for the period set forth in paragraph (a) above.

 

(c)       Furnish
to the Holders such number of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements
of the Securities Act, and such other documents
as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them.

 

    	 	10	 

     

    

 

(d)       Register
and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions
as shall be reasonably requested by the Holders; provided, however, that the Company shall not be required in connection
therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states
or jurisdictions.

 

(e)        In
the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual
and customary form, with the managing underwriter(s) of such offering. Each Holder participating in such underwriting shall also
enter into and perform its obligations under such underwriting agreement.

 

(f)        Cause
all such Registrable Securities registered pursuant to this Agreement to be listed on a national securities exchange or trading
system and each securities exchange and trading system on which similar securities issued by the Company are then listed.

 

(g)       Provide
a transfer agent and registrar for all Registrable Securities registered pursuant hereto and a CUSIP number for all such Registrable
Securities, in each case not later than the effective date of such registration.

 

(h)       Use
its reasonable efforts to furnish, on the date that such Registrable Securities are delivered to the underwriters for sale, if
such securities are being sold through underwriters, those items required to be delivered by or on behalf of the Company to the
underwriters pursuant to the underwriting agreement.

 

(i)       Notwithstanding
any provision in Section 2.2 through Section 2.5 to the contrary, if the Company delivers to the holders requesting registration
pursuant to Section 2.2 or 2.4 a certificate signed by a majority of the then-serving members of the Board stating that in their
good faith judgment, the Company’s obligation to pay (and resulting payment of any) Registration Expenses would (x) not
permitted by or would cause a breach or event of default under any financing agreement to which the Company or any of its Subsidiaries
is a party, or (y) after giving effect to the payment of such Registration Expenses
the Company would not be able to pay its debts as they become due in the usual course of business, then the Company shall not
be required to effect such registration and incur such Registration Expenses until the liquidity constraints described in clauses
(x) and (y) are resolved; provided further that the requesting holders can elect (in their sole discretion) to advance
the cost of such Registration Expenses on behalf of the Company and the Company shall agree to reimburse the cost of such Registration
Expenses on reasonable repayment terms agreed to in good faith between the Company and such requesting holders.

 

2.7       Termination
of Registration Rights. All registration rights
granted under this Section 2 shall terminate and be of no further force and effect upon the earlier of: (a) five (5) years after
the date of the Company’s Initial Offering or (b) the occurrence of an event contemplated by Subsection 3(c) of Part C of
Article IV of the Restated Certificate. In addition, a Holder’s registration rights shall expire if all Registrable Securities
held by and issuable to such Holder (and its affiliates) may be sold in a single transaction pursuant to Rule 144.

 

    	 	11	 

     

    

 

2.8       Delay
of Registration; Furnishing Information.

 

(a)       No
Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result
of any controversy that might arise with respect to the interpretation or implementation of this Section 2.

 

(b)       It
shall be a condition precedent to the obligations of the Company to take any action pursuant to Section 2.2, 2.3 or 2.4 that
the selling Holders shall furnish to the Company such information regarding themselves, the Registrable Securities held
by them and the intended method of disposition of such securities as shall be required to effect the registration of their Registrable
Securities as shall be necessary in order to assure compliance with federal and applicable State Securities Laws.

 

2.9       Indemnification.
In the event any Registrable Securities are
included in a registration statement under Sections 2.2, 2.3 or 2.4:

 

(a)       To
the maximum extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners, officers and directors
of each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities
(joint or several) to which they may become subject under the Securities Act, the Exchange Act or other federal or state
law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any
of the following statements, omissions or violations (collectively a “Violation”) by the Company: (i) any
untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary
prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission
to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or
(iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any State Securities Law
or any rule or regulation promulgated under the Securities Act, the Exchange Act or any State Securities Law in connection with
the offering covered by such registration statement; and the Company will pay, as incurred, to each such Holder, partner, officer,
director, underwriter or controlling person, any legal or other expenses reasonably incurred by them in connection with investigating
or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained
in this Section 2.9(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action
if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall
the Company be liable in any such case for any such loss, claim, damage, liability or action suffered by a Holder to the extent
that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished
by such Holder expressly for use in connection with such registration, which information relates to such person or entity or his
or its relationship with the Company.

 

    	 	12	 

     

    

 

(b)       To
the extent permitted by law, each Holder will, if Registrable Securities held by such Holder are included in the securities as
to which such registration qualifications or compliance is being effected, indemnify and hold harmless the Company, each of its
directors, its officers and each person, if any, who controls the Company within the meaning of the Securities Act, any underwriter
and any other Holder selling securities under such registration statement or any of such other Holder’s partners, directors
or officers or any person who controls such Holder, against any losses, claims, damages or liabilities (joint or several) to which
the Company or any such director, officer, controlling person, underwriter or other such Holder, or partner, director, officer
or controlling person of such other Holder may become subject under the Securities Act, the Exchange Act or other federal or state
law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any
Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with
written information furnished by such Holder to the Company specifically for use in connection with such registration, which information
relates to such person or entity or his or its relationship with the Company; and each such Holder will pay, as incurred, any
legal or other expenses reasonably incurred by the Company or any such director, officer, controlling person, underwriter or other
Holder, or partner, officer, director or controlling person of such other Holder in connection with investigating or defending
any such loss, claim, damage, liability or action if it is judicially determined that there was such a Violation; provided,
however, that the indemnity agreement contained in this Section 2.9(b) shall not apply to amounts paid in settlement
of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent
shall not be unreasonably withheld.

 

(c)       Promptly
after receipt by an indemnified party under this Section 2.9 of notice of the commencement of any action (including any governmental
action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.9,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right
to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed,
to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified
party shall have the right to retain its own counsel, with the fees and expenses to be paid by the indemnifying party, if representation
of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential
differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure
to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if materially
prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party
under this Section 2.9, but the omission so to deliver written notice to the indemnifying party will not relieve it of any
liability that it may have to any indemnified party otherwise than under this Section 2.9.

 

(d)       If
the indemnification provided for in this Section 2.9 is held by a court of competent jurisdiction to be unavailable to an
indemnified party with respect to any losses, claims, damages or liabilities referred to herein, the indemnifying party, in lieu
of indemnifying such indemnified party thereunder, shall to the extent permitted by applicable law contribute to the amount paid
or payable by such indemnified party as a result
of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the indemnifying
party on the one hand and of the indemnified party on the other in connection with the Violation(s) that resulted in such loss,
claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and of the indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying
party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission; provided, however, that in no event shall any contribution by a Holder hereunder
exceed the net proceeds from the offering received by such Holder.

 

    	 	13	 

     

    

 

(e)       The
obligations of the Company and Holders under this Section 2.9 shall survive completion of any offering of Registrable Securities
in a registration statement and the termination of this Agreement. No indemnifying party, in the defense of any such claim or
litigation, shall, except with the consent of
each indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such
claim or litigation.

 

2.10       Assignment
of Registration Rights. The rights to cause
the Company to register Registrable Securities pursuant to this Section 2 may be assigned by a Holder to a transferee or
assignee of Registrable Securities that (a) is a partner or retired partner of any Holder which is a partnership, (b) is a member
or former member of any Holder which is a limited liability company, (c) is a Holder’s family member or trust for the benefit
of an individual Holder, (d) acquires at least five percent (5%) of all Registrable Securities Deemed Outstanding (as adjusted
for stock splits and combinations), or (e) acquires such Registrable Securities in a transfer permitted under Section 2.1(a)(ii);
provided, however, (i) the transferor shall, within ten (10) days after such transfer, furnish to the Company written notice
of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being
assigned and (ii) such transferee shall agree in writing to be subject to all restrictions set forth in this Agreement

 

2.11       Amendment
of Registration Rights. Any provision of this
Section 2 may be amended and the observance thereof may be waived (either generally or in a particular instance and either
retroactively or prospectively), only with the written consent of the Company and the Holders of at least (i) a majority of the
Registrable Securities, and (ii) Rose Capital. Any amendment or waiver effected in accordance with this Section 2.11 shall
be binding upon each Holder and the Company. By acceptance of any benefits under this Section 2, Holders of Registrable Securities
hereby agree to be bound by the provisions hereunder.

 

2.12       Limitation
on Subsequent Registration Rights. Other than
as provided in Section 5.11 hereof, after the date of this Agreement, the Company shall not, without the prior written consent
of the Holders of at least (i) a majority of the Registrable Securities Deemed Outstanding, and (ii) Rose Capital, enter into
any agreement with any holder or prospective holder of any securities of the Company that would grant such holder registration
rights pari passu or senior to those granted to the Holders hereunder, other than the right to a Special Registration Statement.

 

    	 	14	 

     

    

 

2.13       “Market
Stand-Off” Agreement. Each Holder hereby
agrees that such Holder shall not sell, transfer, make any short sale of, grant any option for the purchase of, or enter into
any hedging or similar transaction with the same economic effect as a sale, any Common Stock (or other securities) of the Company
held by such Holder (other than those included in the registration) for a period specified by the representative of the underwriters
of Common Stock (or other securities) not to exceed one hundred eighty (180) days for the Initial Offering and ninety (90) days
for any subsequent public offering; following the effective date of the registration statement filed by the Company under the
Securities Act in connection with an underwritten offering; provided, however, that all officers, directors, employees
and 1% stockholders of the Company (those holding 1% or more of the Company’s Common Stock determined on an as-converted
basis) enter into similar agreements. Notwithstanding anything herein to the contrary, the provisions of this Section 2.13 shall
not apply to any shares purchased in the Initial Offering or in the secondary market following the Initial Offering.

 

2.14       Agreement
to Furnish Information. Each Holder agrees
to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter that are consistent
with the Holder’s obligations under Section 2.13 or that are necessary to give further effect thereto. In addition, if requested
by the Company or the representative of the underwriters of Common Stock (or other securities) of the Company, each Holder shall
provide, within ten (10) days of such request, such information as may be required by the Company or such representative in connection
with the completion of any public offering of the Company’s securities pursuant to a registration statement filed under
the Securities Act. The obligations described in Section 2.13 and this Section 2.14 shall not apply to a Special Registration
Statement. The Company may impose stop-transfer instructions with respect to the shares of Common Stock (or other securities)
subject to the foregoing restriction until the end of the applicable period. Each Holder agrees that any transferee of any shares
of Registrable Securities shall be bound by Sections 2.13 and 2.14. The underwriters of the Company’s stock are intended
third party beneficiaries of Sections 2.13 and 2.14 and shall have the right, power and authority to enforce the provisions hereof
as though they were a party hereto. Each Holder shall use its best efforts to furnish, on the date that such Registrable Securities
are delivered to the underwriters for sale, if such securities are being sold through underwriters, an opinion, dated as of such
date, of the counsel representing such Holder for the purposes of such registration, in form and substance as is customarily given
to underwriters in an underwritten public offering that includes selling stockholders.

 

2.15       Rule
144 Reporting. With a view to making available
to the Holders the benefits of certain rules and regulations of the SEC which may permit the sale of the Registrable Securities
to the public without registration, the Company agrees to use its commercially reasonable efforts to:

 

(a)       Make
and keep public information available, as those terms are understood and defined in Rule 144, at all times after the effective
date of the first registration filed by the Company for an offering of its securities to the general public to the extent required
by applicable law;

 

(b)       File
with the SEC, in a timely manner, all reports and other documents required of the Company under the Exchange Act; and

 

    	 	15	 

     

    

 

(c)       So
long as a Holder owns any Registrable Securities, furnish to such Holder forthwith upon request (i) a written statement by the
Company as to its compliance with the reporting requirements of Rule 144, and of the Exchange Act (at any time after it has become
subject to such reporting requirements), (ii) a copy of the most recent annual or quarterly report of the Company, if any, and
(iii) such other reports and documents as a Holder may reasonably request in availing itself of any rule or regulation of the
SEC allowing it to sell any such securities without registration, and which the Company is able to provide without unreasonable
effort or expense.

 

2.16       Changes
in Common Stock or Preferred Stock. If, and as often as, there is any change in the Common Stock or the Preferred Stock
by way of a stock split, stock dividend, combination, recapitalization, reclassification and the like, or through a merger, consolidation,
reorganization or recapitalization, or by any other means, appropriate adjustment shall be made in the provisions hereof so that
the rights and privileges granted hereby shall continue with respect to the Common Stock and the Preferred Stock as so changed.

 

SECTION
3.COVENANTS
OF THE COMPANY.

 

3.1       Basic
Financial Information and Reporting.

 

(a)       The
Company shall maintain true books and records of account in which full and correct entries will be made of all its business transactions
pursuant to a system of accounting established and administered in substantial accordance with generally accepted accounting principles
consistently applied.

 

(b)       The
Company shall furnish to each Holder of not less than five percent (5%) of the outstanding shares of the Preferred (or an equivalent
amount of the Common Stock issued upon conversion) (each, a “Major Investor”), each Board member and
each Board observer, as soon as practicable after the end of each calendar quarter, and in any event within thirty (30) days thereafter:

 

(i)         as
soon as available but in any event within forty five (45) days after the end of each quarterly accounting period in each fiscal
year, unaudited consolidated statements of income and cash flows of the Company and its Subsidiaries for such quarterly period
and for the period from the beginning of the fiscal year to the end of such quarter, and unaudited consolidated balance sheets
of the Company and its Subsidiaries as of the end of such quarterly period, setting forth in each case comparisons to the annual
Operating Budget (as defined below) and to the corresponding period in the preceding fiscal year, and all such items shall be
prepared in accordance with generally accepted accounting principles, consistently applied;

 

(ii)        as
soon as available but in any event within ten (10) business days after the end of each monthly accounting period in each fiscal
year, a copy of the “Key Performance Indicators” report used by management;

 

    	 	16	 

     

    

 

(iii)       within
one hundred twenty (120) days after the end of each fiscal year:

 

(1)       audited
financial statements of the Company and its Subsidiaries (including a consolidated balance sheet and consolidated statements of
income, cash flows and members’ equity) as of the end of such fiscal year, prepared in accordance with generally accepted
accounting principles, consistently applied, and accompanied by (A) (with respect to the consolidated portions of such statements)
an opinion of an independent accounting firm of recognized national standing reasonably acceptable to the Board and (B) a copy
of such firm’s annual management letter to the Board; and

 

(2)       comparisons
between the audited financial statements and each of (A) the Operating Budget and (B) the preceding Fiscal Year, in each case
prepared in accordance with generally accepted accounting principles, consistently applied;

 

(iv)       within
thirty (30) days prior to the beginning of each fiscal year, a draft of the Operating Budget, and within thirty (30) days after
any monthly period in which there is a material adverse deviation from the Operating Budget, a written explanation of the deviation
and what actions the Company has taken and proposes to take with respect thereto; and

 

(v)         an
updated capitalization table, certified by the Company’s Chief Executive Officer or Chief Financial Officer.

 

(c)       As
soon as practicable after the end of each fiscal year of the Company and in any event within one hundred twenty (120) days thereafter,
the Company shall furnish to each Holder, (i) a balance sheet as of the end of such year, (ii) statements of income and of cash
flows for such year, and (iii) a statement of stockholders’ equity as of the end of such year, all such financial statements
in reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”),
audited and certified by an accounting firm acceptable to the Board.

 

3.2       Operating
Budget. The Company will cause its management to prepare and submit to the Board and Rose Capital no later than thirty
(30) days prior to the commencement of each fiscal year, an annual budget and plan for such fiscal year, which shall include the
Company’s forecasted revenues, expenses, and cash position (together with reasonably detailed supporting materials regarding
the assumptions used in the preparation of such statements of income and cash flows and balance sheets) on a month-to-month basis
for the upcoming fiscal year, together with management’s written discussion and analysis of such budget and plan (collectively,
the “Operating Budget”). The Operating Budget shall be accepted as the budget for such fiscal year when
it has been approved by the Board and Rose Capital (which approval by Rose Capital shall be provided in good faith and shall not
be unreasonably withheld, conditioned or delayed). Upon approval, a copy of such budget as so approved promptly shall be sent
to each Major Investor. The Company shall review the Operating Budget periodically and shall promptly advise the Board and each
Major Investor of all changes therein and all material deviations therefrom.

 

3.3       Inspection.
The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the Company’s
properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with
its officers, all at such reasonable times as may be reasonably requested by such Major Investor.

 

    	 	17	 

     

    

 

3.4       Confidentiality
of Records. Each Investor agrees to use, and to use its best efforts to insure that its representatives use, the same
degree of care as an Investor uses to protect its own confidential information to keep confidential any information furnished
by the Company to such Investor and identifies as being confidential or proprietary (so long as such information is not in the
public domain), except that such Investor may disclose such confidential or proprietary information to any partner, subsidiary
or parent of such Investor for the purpose of evaluating its investment in the Company as long as such partner, subsidiary or
parent is advised of the confidentiality provisions of this Section 3.4.

 

3.5       Payment
of Corporate Taxes; Corporate Existence and Licenses; Maintenance of Properties. The Company shall:

 

(a)       (i)
Pay and discharge promptly, or cause to be paid and discharged promptly, when due and payable, all taxes, assessments and governmental
charges or levies imposed upon it or upon its income or upon any of its property or upon any part thereof, as well as all claims
of any kind (including claims for labor, materials and supplies) which, if unpaid, might by law become a lien, charge or encumbrance
upon its property; (ii) withhold all monies required to be withheld by the Company from employees for income taxes, Social Security
and unemployment insurance taxes; and (iii) complete and file, on a timely basis, all tax returns and reports required to
be filed by it; provided, however, that the Company shall not be required to pay any tax, assessment, charge, levy or claim
if the amount, applicability or validity thereof shall currently be contested in good faith by appropriate proceedings and if
the Company shall have set aside on its books reserves (segregated to the extent required by generally accepted accounting principles)
deemed by the Company adequate with respect thereto;

 

(b)       Do
or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence, and all of its
corporate rights, franchises, licenses and permits that are material to its business; provided, however, that nothing in
this subsection (b) shall (i) prevent the abandonment or termination of the Company’s or any subsidiary’s
authorization to do business in any foreign state or jurisdiction, if, in the opinion of the Board, such abandonment or termination
is in the best interest of the Company or such subsidiary, (ii) require compliance with any law so long as the validity or
applicability thereof shall be disputed and contested in good faith, or (iii) prevent the Company from effecting a merger,
consolidation or voluntary dissolution upon obtaining the required approval, if any, of such Board and/or the stockholders of
the Company; and

 

(c)       Maintain
and keep, or cause to be maintained and kept, its property in working order and condition (subject to ordinary wear and tear),
and from time to time make, or cause to be made, all repairs, renewals and replacements which, in the opinion of the management
of the Company, are necessary and proper so that the business carried on in connection therewith may be properly and advantageously
conducted at all times; provided, however, that nothing in this subsection (c) shall prevent the Company or any subsidiary
from selling or otherwise disposing of any property  whenever in the good faith judgment of the Company’s management
such property is obsolete, worn out, without economic value, or unnecessary for the conduct of the business of the Company or
such subsidiary.

 

    	 	18	 

     

    

 

3.6       Insurance.
The Company shall keep all of its insurable property insured against loss or damage by fire and other risks. The Company
shall bind D&O insurance with a carrier and in an amount satisfactory to the Board and Rose Capital. In the event the Company
merges with another entity and is not the surviving entity, or transfers all of its assets, the Company shall take reasonable
efforts to ensure that the successors of the Company assume the Company’s obligations with respect to indemnification of
Directors.

 

3.7       Maintenance
and Protection of Intellectual Property. The Company shall use its commercially reasonable efforts to maintain all
Proprietary Rights and all applications and registrations therefor owned or held by the Company or hereafter owned or held by
the Company in full force and effect in the United States and, except where application, registration, or maintenance of any registration
or patent would not be, in the reasonable judgment of the Board, cost-effective, in other countries in which the Company shall
engage in business, including, but not limited to, (a) the prosecution of applications to register or perfect rights or claims
in and to any Proprietary Rights, (b) the registration of license agreements, the timely filing of affidavits of use, renewals,
or other maintenance filings, and (c) the timely payment of filing, issue and maintenance fees. The Company shall not abandon
or let lapse or pass to the public domain any of the Proprietary Rights now or hereafter owned or held by the Company that are
material to its business, shall not encumber or license others to use the Proprietary Rights owned by it except in the ordinary
course of the Company’s business, and shall maintain the confidentiality and trade secret status of all Proprietary Rights
that are confidential except where and only to the extent that disclosure is necessary to obtain copyright registrations or patents,
or is necessary or desirable in the prudent conduct of the Company’s business.

 

3.8       Employee
Confidentiality Agreements. The Company will cause each person now or hereafter employed by it or any subsidiary (or
engaged by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or
trade secrets to enter into a non-disclosure and proprietary rights assignment agreement.

 

3.9       Related
Party Transactions. The Company will not enter into or be a party to any transaction with any director, officer or
employee of the Company or any “associate” (as defined in Rule 12b-2 promulgated under the Exchange Act) of any such
person, except for transactions contemplated by this Agreement and the Purchase Agreement, transactions resulting in payments
to or by the Company in an amount less than $25,000 per year, or transactions made in the ordinary course of business and pursuant
to reasonable requirements of the Company’s business and upon fair and reasonable terms that are approved by Rose Capital.
The term “non-employee director” has the meaning assigned to such term in the Commission’s Rule
16b-3.

 

3.10       Matters
Requiring Rose Capital Approval. Without the prior approval of Rose Capital, the Company shall not:

 

(a)       issue
or authorize any class or series of equity securities or equivalents (except pursuant to an award approved by the Board which
award is within the Authorized Pool) without complying with Section 4 herein;

 

(b)       effect
any transaction that results in a Change in Control, unless such Change in Control will result in Rose Capital receiving a return
cash-on-cash multiple to Rose Capital on its investment in the Series B Preferred of at least 3.0x, and in the event such return
threshold is satisfied, Rose Capital shall consent to such transaction in accordance with Section 2.2 of the Voting Agreement
and the Charter;

 

    	 	19	 

     

    

 

(c)       incur
any aggregate indebtedness in excess of $200,000, other than trade credit incurred in the ordinary course of business;

 

(d)       enter
into or be a party to any transaction with any director, officer or employee of the Company or any “associate” (as
defined in Rule 12b-2 promulgated under the Exchange Act) of any such person;

 

(e)       change
the principal business of the Company, enter new lines of business, or exit the current line of business;

 

(f)       sell,
transfer, license, pledge or encumber assets (including technology or intellectual property) in excess of $100,000, other than
licenses granted in the ordinary course of business;

 

(g)       any
acquisition in excess of $100,000;

 

(h)       approve
the Operating Budget or pay employee bonuses except for ordinary course employee bonuses to employees (other than any Helix Opps
Company Executive) in the amounts included in the Operating Budget;

 

(i)       adoption
or modification of any management incentive plan which provides for awards in excess of 1,501,758 shares of Common Stock (the
“Authorized Pool”), any attempted increase in the size of the Authorized Pool or the issuance of any
awards under any management incentive plan outside of the Authorized Pool;

 

(j)       hiring,
terminating or modifying the terms of any employment or consulting relationship, as applicable, with the President or Chief Executive
Officer, Chief Financial Officer or Chief Operating Officer, except that, subject to Section 3.11(c), the Chief Executive Officer
shall have full discretion to hire Scott Ogur as the Company’s first Chief Financial Officer;

 

(k)       the
making of aggregate capital expenditures for the Company or any of its Subsidiaries in excess of 20% of amounts set forth on the
Operating Budget; or

 

(l)       declare
or pay any dividend or make any distribution on any shares of capital stock of the Company.

 

3.11       Board
Matters; Rose Management Compensation For Management and Key Management Compensation.

 

(a)       Unless
otherwise agreed by a unanimous vote of the members of the Board, the Board shall meet at least four times per year and if Rose
Capital is not represented by a formal member of the Board, Rose Capital shall be entitled to attend such meeting in a non-voting
observer capacity. The Company shall reimburse the Directors (and any Rose Capital observer) all reasonable out-of-pocket expenses
incurred in performance of their duties as directors.

 

    	 	20	 

     

    

 

(b)       In
connection with the establishment of the Operating Budget for 2018 and continuing until the occurrence of a Rose Capital Selldown
Event and in exchange for Management Services provided by Rose Management during such time period, the Company shall pay aggregate
compensation to Rose Management Group LLC (or such other person or entity as designated by Rose Capital to the Company in writing)
(“Rose Management”) a management fee in amount agreed to in writing by Rose Capital and the Company,
which management fee shall payable quarterly in arrears (the “Rose Management Fees”). Notwithstanding
any provision in this Section 3.11(b) to the contrary, if the Company determines in its reasonable, good faith judgment (after
consultation with Rose Management) that the Company’s obligation to pay (and resulting payment of any) Rose Management Fees
would (x) not permitted by or would cause a breach or event of default under any financing agreement to which the Company or any
of its Subsidiaries is a party, or (y) after giving effect to the payment of such Rose Management Fees, the Company would not
be able to pay its debts, operating expenses or other liabilities as they become due in the usual course of business, then the
Company shall not be required to pay such Rose Management Fees and any such unpaid amounts shall accrue until the liquidity constraints
described in the foregoing clauses (x) and (y) are resolved; provided further that, in lieu of accruing such fees, Rose
Management may elect to receive the unpaid Rose Management Fees in shares of the Company’s stock equal to the fair market
value of such unpaid fees (as mutually agreed upon in writing by the Company and Rose Management).

 

(c)       To
the extent that Zachary Venegas and Scott Ogur serve as the full-time Chief Executive Officer and Chief Financial Officer, respectively
(each, a “Helix Opps Company Executive”), each such Helix Opps Company Executive shall be entitled to
up to $200,000 (or such lower amount agreed to between the Company and each such Helix Opps Company Executive) of cash compensation.
No Helix Opps Company Executive shall be entitled to any annual bonus without the prior written consent of Rose Capital; provided
that no Rose Capital consent shall be required to pay any reasonable bonus earned by Scott Ogur as long as such bonus was reflected
in the Operating Budget for such period and the applicable bonus targets were satisfied.

 

3.12       Termination
of Covenants. All covenants of the Company contained in this Section 3 shall expire and terminate as to each Investor
or Holder of Registrable Securities, as applicable, upon the earlier of (a) the effective date of the registration statement
pertaining to the Initial Offering, (b) upon a Change in Control which is consented to by Rose Capital or otherwise complies
with Section 3.10(b), or (c) the date on which Rose Capital or its Affiliates transfers or sells to an unaffiliated third party
more than seventy five percent (75%) of Equity Securities (whether in the form of Series B Preferred or any other class of Equity
Securities in which the Series B Preferred are converted into) acquired by Rose Capital pursuant to the Purchase Agreement (the
event described in the foregoing clause (c), a “Rose Capital Selldown Triggering Event”).

 

SECTION
4.PARTICIPATION
RIGHTS.

 

4.1       Subsequent
Offerings. Each Major Investor shall have a right to purchase such Major Investor’s pro rata share of
all Equity Securities that the Company may, from time to time, propose to sell and issue after the date of this Agreement, other
than the Equity Securities excluded by Section 4.7 hereof. Each Major Investor’s pro rata share is equal to the ratio
of (a) the number of shares of the Company’s outstanding Common Stock (treating all shares of convertible preferred
stock or warrants to acquire convertible preferred stock on an as-converted to common stock basis and including all shares of
Common Stock issuable upon the exercise of outstanding warrants or options) which such Major Investor holds of record immediately
prior to the issuance of such Equity Securities to (b) the total number of shares of the Company’s outstanding Common
Stock (treating all shares of convertible preferred stock or warrants to acquire convertible preferred stock on an as-converted
to common stock basis and including all shares of Common Stock issuable upon the exercise of outstanding warrants or options)
immediately prior to the issuance of such Equity Securities.

 

    	 	21	 

     

    

 

4.2       Exercise
of Rights. If the Company proposes to issue any Equity Securities, it shall give each Major Investor written notice
of its intention, describing the Equity Securities, the price and the terms and conditions upon which the Company proposes to
issue the same. Each Major Investor shall have ninety (90) days (the “Preemptive Rights Period”) from
the giving of such notice to agree to purchase its pro rata share of the Equity Securities for the price and upon the terms
and conditions specified in the notice by giving written notice to the Company and stating therein the quantity of Equity Securities
to be purchased; provided that the Preemptive Rights Period shall be reduced to thirty (30) days commencing on and after
March 31, 2018.

 

4.3       Issuance
of Equity Securities to Other Persons. If not all of the Major Investors elect to purchase their pro rata share
of the Equity Securities, then the Company shall promptly notify in writing the Major Investors that have so elected (the “Participating
Investors”) and offer the Participating Investors the right to acquire such unsubscribed shares. Each Participating
Investor shall have five (5) business days after receipt of such notice to notify the Company of such Participating Investor’s
election to purchase all or a portion thereof of the unsubscribed shares. If the Major Investors fail to exercise in full the
participation rights set forth in Section 4.2 hereof and this Section 4.3, the Company shall have ninety (90) days thereafter
to sell the Equity Securities in respect of which the Major Investors’ rights were not exercised, at a price and upon terms
and conditions no more favorable to the purchasers thereof than specified in the Company’s original notice of the sale of
such Equity Securities to the Major Investors pursuant to Section 4.2 hereof. If the Company has not sold such Equity Securities
within ninety (90) days of such notice, the Company shall not thereafter issue or sell any Equity Securities, without first offering
such securities to the Major Investors in the manner provided above.

 

4.4       Termination
and Waiver of Participation Rights. The participation rights established by this Section 4 shall not apply to, and
shall terminate upon the earlier of (a) the effective date of the registration statement pertaining to the Company’s
Initial Offering, or (b) a Change in Control. The participation rights set forth in this Section 4 may be amended, or any
provision waived, with the written consent of Major Investors (which consent must also include the consent of Rose Capital) holding
a majority of the shares of Common Stock held by such Major Investors (treating all shares of convertible preferred stock or warrants
to acquire convertible preferred stock on an as-converted to common stock basis), or as permitted by Section 5.5.

 

4.5       Transfer
of Participation Rights. The participation rights set forth in this Section 4 are transferable, subject to the same
limitations set forth in Section 2.10 hereof.

 

4.6       [RESERVED].

 

4.7       Excluded
Securities. The participation rights set forth in this Section 4 shall not apply to the following Equity Securities:

 

(a)       shares
of the Common Stock issued or issuable upon conversion of any shares of the Preferred Stock;

 

(b)       [RESERVED];

 

(c)       shares
of the Common Stock, including options, warrants or other rights to purchase up to such number of shares of the Common Stock (as
adjusted for any stock dividends, combinations, splits, recapitalizations and the like), issued, sold or granted to employees,
officers or directors of, or consultants or advisors to the Company or any subsidiary pursuant to stock purchase or stock option
plans or other arrangements that are approved by Rose Capital;

 

(d)       shares
of the Common Stock issued in connection with any stock split, stock dividend or recapitalization by the Company;

 

(e)       shares
of the Common Stock or the Preferred Stock issued or issuable pursuant to the exercise of options, warrants or Convertible Securities
outstanding as of the date hereof;

 

(f)       shares
of the Common Stock or Preferred Stock and/or options, warrants or other rights to purchase the Common Stock or the Preferred
Stock issued or issuable for consideration other than cash pursuant to a merger, consolidation, acquisition, strategic alliance
or similar business combination approved by Rose Capital; and

 

(g)       any
equity securities issued or issuable in connection with strategic transactions involving the Company and other entities, including
(i) joint ventures, manufacturing, marketing or distribution arrangements or (ii) technology transfer or development arrangements;
provided, however, that the issuance of shares therein has been approved by the Board; and

 

(h)       any
Equity Securities that are issued by the Company pursuant to a registration statement filed under the Securities Act.

 

    	 	22	 

     

    

 

SECTION
5.MISCELLANEOUS.

 

5.1       Governing
Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware, without regard to its principles of conflicts of laws. Each of the parties hereto irrevocably
submits to the exclusive jurisdiction of the courts of the State of Delaware located in Wilmington and the United States District
Court for the District of Delaware for the purpose of any suit, action, proceeding or judgment relating to or arising out of this
Agreement and the transactions contemplated hereby.  Service of process in connection with any such suit, action or proceeding
may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under
this Agreement.  Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit,
action or proceeding and to the laying of venue in such court.  Each party hereto irrevocably waives any objection to the
laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit,
action or proceeding brought in any such court has been brought in an inconvenient forum.  EACH OF THE PARTIES HERETO WAIVES
ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED
SPECIFICALLY AS TO THIS WAIVER.

 

5.2       Successors
and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and
be binding upon, the successors, assigns, heirs, executors, and administrators of the parties hereto and shall inure to the benefit
of and be enforceable by each person who shall be a holder of Registrable Securities from time to time; provided, however,
that prior to the receipt by the Company of adequate written notice of the transfer of any Registrable Securities specifying
the full name and address of the transferee, the Company may deem and treat the person listed as the holder of such shares in
its records as the absolute owner and holder of such shares for all purposes, including the payment of dividends or any redemption
price.

 

5.3       Entire
Agreement. This Agreement, together with (i) that certain Right of First Refusal and Co-Sale Agreement (the “ROFR/Co-Sale
Agreement”) by and among the Company, the Key Holders (as defined therein) and the Investors dated as of the date
hereof; (ii) that certain Voting Agreement (the “Voting Agreement”) by and among the Company, the Key
Holders (as defined therein) and the Investors dated as of the date hereof; and (iii) only as to Rose Capital, that certain Series
B Preferred Stock Purchase Agreement, of even date herewith, constitute the full and entire understanding and agreement between
the parties with regard to the subjects hereof and thereof and no party shall be liable or bound to any other in any manner by
any representations, warranties, covenants and agreements except as specifically set forth herein and therein.

 

5.4       Severability.
In the event one or more of the provisions of this Agreement should, for any reason, be held to be invalid, illegal
or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions of this
Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained
herein.

 

    	 	23	 

     

    

 

5.5       Amendment
and Waiver.

 

(a)       Except
as otherwise expressly provided herein, this Agreement may be amended or modified only upon the written consent of the Company
and the holders of at least a (i) majority of the Registrable Securities and (ii) Rose Capital. Any such amendment or modification
effected in accordance with this Section 5.5(a) shall be binding on all parties hereto, even if they do not execute such consent.

 

(b)       Subject
to Section 5.5(c) below, any party hereto may waive compliance with any agreements, covenants or conditions for the benefit of
such party contained herein. Any agreement on the part of a party hereto to any such waiver shall be valid only if set forth in
an instrument in writing signed on behalf of such party.

 

(c)       Except
as otherwise expressly provided, the obligations of the Company and the rights of the Holders under this Agreement may be waived
with respect to all parties to this Agreement (either generally or in a particular instance and either retroactively or prospectively)
only with the written consent of the holders of (i) at least a majority of the Registrable Securities and (ii) Rose Capital. Any
such waiver effected in accordance with this Section 5.5(c) shall be binding on all parties hereto, even if they do not execute
such consent. Each Holder acknowledges that by the operation of this paragraph, the holders of (i) a majority of the Registrable
Securities (excluding any of such shares that have been sold to the public or pursuant to Rule 144) and (ii) and (ii) Rose Capital,
each voting separately, will have the right and power to diminish or eliminate all rights of such Holder under this Agreement.

 

(d)       For
the purposes of determining the number of Holders or Investors entitled to vote or exercise any rights hereunder, the Company
shall be entitled to rely solely on the list of record holders of its stock as maintained by or on behalf of the Company.

 

5.6       Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any person or entity hereunder
(including, without limitation, any Holder), upon any breach, default or noncompliance of the Company under this Agreement shall
impair any such right, power, or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance,
or any acquiescence therein, or of any similar breach, default or noncompliance thereafter occurring. Any waiver, permit, consent,
or approval of any kind or character on any such person’s or entity’s part of any breach, default or noncompliance
under the Agreement or any waiver on such person or entity’s part of any provisions or conditions of this Agreement must
be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this
Agreement, by law, or otherwise afforded to any such person or entity, shall be cumulative and not alternative.

 

5.7       Notices.
All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon
personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient; if not, then on the next business day, (c) five (5) days after having been sent by registered
or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized
overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the
party to be notified at the address as set forth herein or at such other address as such party may designate by ten (10) days
advance written notice to the other parties hereto.

 

    	 	24	 

     

    

 

5.8       Bad
Actor Notice Requirement. Each party to this Agreement will promptly notify each other party to this Agreement in writing
if it or, to its knowledge, any of such party’s directors or executive officers becomes subject to any Bad Actor Disqualification
(as such term is defined in the ROFR/Co-Sale Agreement).

 

5.9       Attorneys’
Fees. In the event that any suit or action is instituted to enforce any provision in this Agreement, the prevailing
party in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of
such prevailing party under or with respect to this Agreement, including, without limitation, such reasonable fees and expenses
of attorneys and accountants, which shall include, without limitation, all fees, costs and expenses of appeals.

 

5.10       Titles
and Subtitles. The titles of the sections and subsections of this Agreement are for convenience of reference only and
are not to be considered in construing this Agreement.

 

5.11       Additional
Investors. Notwithstanding anything to the contrary contained herein, if the Company shall issue additional shares
of the Preferred, any purchaser of such shares of the Preferred shall become a party to this Agreement by executing and delivering
an additional counterpart signature page to this Agreement and shall be deemed an “Investor,” a “Holder”
and a party hereunder.

 

5.12       Aggregation
of Stock. All shares of Registrable Securities held or acquired by affiliated entities or persons, or persons (which,
with respect to a partnership, shall include its general and limited partners, as well as the members or partners of any general
partner of such partnership) or entities under common management or control shall be aggregated together for the purpose of determining
the availability of any rights under this Agreement.

 

5.13       Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which
together shall constitute one instrument. This Agreement may be executed by facsimile signatures or by .pdf signature.

 

Signatures
on the Following Pages

 

    	 	25	 

     

    

 

The
parties hereto have executed this Investor Rights Agreement as of the date
set forth in the first paragraph hereof.

 

	THE COMPANY:	 
	 	 
	Helix TCS, Inc.	 
	 	 	 
	By: 	 	 
	Name:	Zachary L. Venegas	 
	Its:	Chief Executive Officer	 
	 	 	 
	THE PRIOR INVESTORS:	 
	 	 
	KEY HOLDERS:	 
	 	 
	Helix Opportunities, LLC	 
	 	 	 
	By: 	 	 
	Name:	Zachary L. Venegas	 
	Its:	Director	 

 

    	 	A-2	 

     

    

 

The
parties hereto have executed this Investor Rights Agreement as of the date
set forth in the first paragraph hereof.

 

	ROSE
    CAPITAL:	 
	 	 
	RSF4, LLC	 
	 	 	 
	By: 	 	 
	Name:	       	 
	Title: 	 	 
	 	 	 
	By: 	 	 
	Name:	 	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}]]